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Abstract 
Small inorganic assemblies of alternating ferrous/ferric iron and sulphide ions, so-
called iron–sulphur (Fe–S) clusters, are probably nature‟s most ancient prosthetic 
groups. These multipurpose reactive centres are biosynthesised by dedicated Fe–S 
cluster assembly proteins which are conserved in the mitochondria of all eukaryotes. 
One of the early actors in Fe–S cluster biosynthesis is a cysteine desulphurase, Nfs1, 
which catalyses the release of elemental sulphur from cysteine and plays a key role 
in its transfer to a molecular scaffold. Recent work has discovered that these 
reactions require the involvement of a small adaptor protein, Isd11. Isd11 belongs to 
the LYR family of proteins and helps stabilise Nfs1 upon binding. In this Thesis, 
heterologous production of soluble yeast Nfs1 on its own as well as in complex with 
yeast Isd11 in E. coli is presented. In the absence of Nfs1, Isd11 aggregated in the 
form of inclusion bodies from which the in vitro recovery of soluble protein could 
not be achieved. Both Nfs1 and the Nfs1/Isd11 complex were shown to be active, 
reflecting the correct fold of Nfs1. Biophysical approaches were used to provide new 
insights into the stoichiometry and structure of the Nfs1/Isd11 complex. 
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Chapter 1:   Introduction 
1.1 Background and motivation 
Iron–sulphur (Fe–S) clusters, which are small inorganic assemblies of iron and 
sulphur, are among the most ubiquitous co-factors used by many biological systems 
in a number of reactions. These multipurpose structures were originally discovered in 
the early 1960s as reactive centres in electron-transfer proteins engaged in such 
crucial biological processes as respiration and photosynthesis. Since then, they have 
been reported in all living organisms, from bacteria to mammals. Organisms 
assemble Fe–S clusters using dedicated systems, each consisting of several to many 
proteins. Interestingly, it is only over the last two decades that these proteins 
involved in the assembly of Fe–S clusters have begun to be documented. Some of the 
Fe–S cluster assembly proteins have been shown to cause disease in humans. 
Apparently, recent discoveries in the field of Fe–S cluster assembly present inspiring 
challenges for a broad range of researchers, including molecular and structural 
biologists. 
1.2 Thesis structure 
The main body of this Thesis begins with an introductory section focusing on the 
structures and functions of biological, or protein-bound, Fe–S clusters. This section 
provides insight into the emergence of Fe–S clusters as co-factors of many proteins 
and explains their structural and functional versatility, using examples. The next 
section features the proteins and mechanisms involved in the assembly of Fe–S 
clusters in a eukaryotic cell, with particular emphasis on yeast. This section is 
followed by a brief section outlining five human diseases that have been linked to 
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defects (mutations) in the genes encoding the Fe–S cluster assembly proteins. The 
next three sections of Chapter 1 detail the eukaryotic cysteine desulphurase Nfs1, its 
functional binding partner Isd11 and their specific complex Nfs1/Isd11, respectively. 
The indispensable Nfs1/Isd11 cysteine desulphurase complex of the Fe–S cluster 
assembly apparatus, which has not been studied in depth before, is the primary 
subject of this PhD Thesis. Chapter 3 includes the heterologous production and 
bioinformatic investigation of yeast Isd11. Chapter 4 specifies the heterologous 
production, biophysical characterisation and comparative modelling of yeast Nfs1. 
Chapter 5 is dedicated to the heterologous production and biophysical 
characterisation of the yeast Nfs1/Isd11 protein complex and the measurements of 
the Nfs1–Isd11 interaction by spectroscopic means. Chapter 2 describes the materials 
and methods used in the experimental work, and Chapter 6 concludes with a 
discussion of what was achieved and what were the major bottlenecks in this project. 
Chapter 6 also offers suggestions on novel and testable strategies for future 
experiments. 
1.3 Biological (protein-bound) Fe–S clusters 
Since the appearance of the first organisms on Earth, cyclic transformations of the 
primary biogenic elements (carbon, hydrogen, nitrogen, oxygen, phosphorus, and 
sulphur) have been pivotal events that support life. Cycles involving the oxidation 
and reduction of these elements provide organisms with usable energy and the 
building blocks of cellular structures. In today‟s life forms, enzymes bearing Fe–S 
clusters are usually involved in these transformations. It is therefore likely that Fe–S 
clusters are among the earliest co-factors available for enzyme catalysis, holding a 
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mirror to naturally occurring chemical transformations in the primordial world with a 
highly reductive atmosphere (Rees & Howard, 2003). 
1.3.1 Structural aspects of Fe–S clusters 
Most frequently, protein-bound Fe–S clusters arise in nature as rhombic, [2Fe–2S], 
or cubic, [4Fe–4S], types in which iron ions are co-ordinated by thiolate sulphur of 
cysteinyl residues of the apoprotein and bridged to each other by inorganic sulphide 
ions (Figure 1.1). While iron can adopt oxidation states of Fe
2+
and Fe
3+
, sulphur is 
invariably present in the S
2-
 oxidation state. A relatively rare type, [3Fe–4S], is 
formed via the loss of one iron atom from one corner of the [4Fe–4S] cluster (Figure 
1.1). The [3Fe–4S] cluster serves as a building block for the assembly of more 
complex clusters (Beinert, 2000). 
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Figure 1.1 Chemical structures and names of the most commonly encountered Fe–S clusters. The 
simplest [2Fe–2S] cluster consists of two iron ions bridged by two sulphide ions and co-ordinated by 
four cysteinyl ligands (in [2Fe–2S] ferredoxins) or by two cysteines and two histidines (in Rieske 
proteins). The [3Fe–4S] centre, which features one iron ion less than the more common [4Fe–4S] 
cluster, consists of three sulphide ions that bridge two iron ions each, while the fourth sulphide 
bridges three iron ions. The common [4Fe–4S] motif features four iron ions and four sulphide ions 
placed at the vertices of a cubane-type structure. These centres are typically further co-ordinated by 
cysteinyl ligands. Sγ in the structural formulae represents the sulphur atom of a cysteinyl residue in 
the peptide backbone co-ordinating the Fe–S cluster. This figure was prepared using ChemDraw 
(http://www.cambridgesoft.com/). 
1.3.2 Functional aspects of Fe–S clusters 
The structural versatility and chemical reactivity of Fe–S clusters have allowed for 
their selection as co-factors for many proteins, enabling these proteins to gain novel 
functions. It is therefore not surprising that proteins harbouring Fe–S cores (termed 
Fe–S proteins) are present in all organisms and play crucial roles in several cellular 
processes including electron transfer, biosynthesis, central metabolism, regulation of 
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gene expression, RNA modification, and DNA repair and replication (see reviews by 
Lill et al., 2006; Lill & Mühlenhoff, 2008; Sheftel et al., 2010). To date, about 20 
different Fe–S proteins with a range of cellular functions have been discovered in 
yeast (Table 1.1). 
Table 1.1 Compilation of Fe–S proteins involved in various functions in yeast.  
Protein Name Cluster(s) present Function 
Sdh2 Complex II 
[2Fe–2S], [3Fe–4S], 
[4Fe–4S] 
Component of the respiratory 
(electron transport) chain 
Rip1 Complex III 
[2Fe–2S]         
(Rieske-type) 
Component of the respiratory 
(electron transport) chain 
Yah1 Ferredoxin [2Fe–2S] 
Provides electrons for mitochondrial 
Fe–S cluster assembly 
Lip5 Lipoate synthase [4Fe–4S], [4Fe–4S] Lipoic acid biosynthesis 
Bio2 Biotin synthase [2Fe–2S], [4Fe–4S] Biotin biosynthesis 
Lys4 Homoaconitase [4Fe–4S] Lysine biosynthesis 
Ilv3 
Dihydroxy-acid 
dehydratase 
[4Fe–4S] 
Branched-chain amino acid 
biosynthesis 
Leu1 
Isopropylmalate 
isomerase 
[4Fe–4S] Leucine biosynthesis 
Glt1 
Glutamate 
dehydrogenase 
[4Fe–4S] Glutamate biosynthesis 
Ecm17 Sulphite reductase [4Fe–4S] Methionine biosynthesis 
Aco1 Aconitase [4Fe–4S] Tricarboxylic acid (TCA) cycle 
Nbp35 
Nucleotide-binding 
protein 35 
[4Fe–4S], [4Fe–4S] Cytosolic Fe–S cluster assembly 
Nar1 
Nuclear architecture-
related protein 1 
Complex-type Cytosolic Fe–S cluster assembly 
Rli1 
RNase L inhibitor 
protein 1 
[4Fe–4S], [4Fe–4S] 
Translation initiation; ribosome 
assembly 
Elp3 
Elongator complex 
protein 3 
[4Fe–4S] 
Transcription elongation; tRNA 
modification 
Tyw1 
tRNA wybutosine-
synthesising protein 1 
[4Fe–4S] tRNA modification 
Ntg2 DNA glycosylase [4Fe–4S] DNA damage repair 
Rad3 DNA helicase [4Fe–4S] DNA damage repair 
Pri2 
DNA primase large 
subunit 
[4Fe–4S] DNA replication 
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1.4 Formation of Fe–S clusters in eukaryotes 
Although Fe–S clusters are simply composed of ferrous (Fe2+) and/or ferric (Fe3+) 
iron and inorganic sulphide (S
2-
) ions, their in vivo assembly and onward delivery to 
recipient apoproteins is notably complex. In eukaryotes, a proteinaceous iron–
sulphur cluster (ISC) assembly machinery, which is conserved from yeast to man, is 
responsible for the assembly process. Components of the eukaryotic ISC system are 
derived from their prokaryotic counterparts and originally arrived with the 
endosymbiont that gave rise to the mitochondrion. The eukaryotic ISC system is still 
primarily, or exclusively, localised in mitochondria. 
1.4.1 Yeast as a model eukaryote 
The yeasts, which are unicellular ascomycetes or „sac fungi‟, are considered to be 
one of the best organisms for the study of eukaryotic biology because the basic 
mechanisms of DNA replication, gene expression, cell division, and metabolism are 
largely conserved between yeasts and higher eukaryotes including mammals. Baker‟s 
yeast (Saccharomyces cerevisiae) was the first eukaryote whose genome 
(approximately 6,000 genes distributed throughout 16 chromosomes) was completely 
sequenced (Goffeau et al., 1996). It was also the first organism for which a whole-
proteome microarray was developed (Zhu et al., 2001). Among other features that 
make S. cerevisiae a model eukaryote for biological research are its GRAS 
(Generally Recognised As Safe) status, ease of cultivation, and rapid growth. 
In addition to whole-proteome studies, comprehensive proteomic analyses of 
different subcellular compartments, such as mitochondria, were also undertaken in S. 
cerevisiae (Sickmann et al., 2003; Reinders et al., 2006). Yeast mitochondria contain 
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approximately 1,000 different proteins, most of which are encoded by nuclear genes. 
Surprisingly, only a few percent of mitochondrial proteins of known function are 
strictly essential for cell viability. These proteins are primarily involved in three 
processes: Fe–S cluster assembly (see Section 1.4.2), protein folding or protein 
translocation. Complete characterisation of the yeast mitochondrial proteome and 
functional assignment of mitochondrial proteins, with particular emphasis on those 
being essential for cell viability, will provide insights into the role of mitochondria in 
health and disease. 
1.4.2 Components of the Fe–S cluster assembly machinery 
Prokaryotic Fe–S cluster biogenesis has been extensively studied in the nitrogen-
fixing bacterium Azotobacter vinelandii, the common intestinal bacterium 
Escherichia coli and the plant pathogen Erwinia chrysanthemi. Genetic and 
biochemical studies have identified three distinct systems by which bacteria build 
Fe–S clusters: the NIF (nitrogen fixation) system, for the specific maturation of 
nitrogenase; the ISC (iron–sulphur cluster) system, for the general maturation of   
Fe–S proteins; and the SUF (sulphur utilisation factor) system, for the maturation of 
Fe–S proteins under conditions of oxidative stress and iron deprivation. The 
evolutionary maintenance of these dedicated Fe–S cluster biogenesis systems 
addresses the change from a reductive to an oxidative environment, the latter 
supporting neither the formation nor the stability of Fe–S clusters (see reviews by 
Johnson et al., 2005a; Fontecave & Ollagnier-de-Choudens, 2008; Py & Barras, 
2010). 
Two of the three prokaryotic Fe–S cluster biogenesis systems, the ISC and SUF 
systems, have been inherited by eukaryotes. At present, homologues of major 
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components of the ISC assembly machinery are maintained in mitochondria, and 
homologues of the major components of the relatively oxygen-stable SUF machinery 
are maintained in plastids (Lill & Mühlenhoff, 2008). Strikingly, the intestinal 
parasite Entamoeba histolytica  (Ali et al., 2004; van der Giezen et al., 2004) and the 
free-living amoeba Mastigamoeba balamuthi (Gill et al., 2007) do not possess the 
ISC system; they rather use the non-redundant NIF system, which has been acquired 
by lateral gene transfer from ε-proteobacteria, for the biogenesis of nascent Fe–S 
clusters. This thesis will focus exclusively on Fe–S cluster assembly in non-plant 
eukaryotes, featuring yeast as a model organism. 
Eukaryotes possess Fe–S proteins in diverse subcellular compartments. 
Mitochondrial Fe–S proteins are formed by the involvement of the ISC assembly 
machinery, and cytosolic/nuclear Fe–S proteins are formed by the involvement of 
both the ISC assembly machinery and the cytosolic iron–sulphur cluster assembly 
(CIA) machinery. Like components of the ISC assembly machinery, components of 
the CIA machinery are also essential for cell viability in yeast. CIA proteins reside in 
the cytosol and can only build cytosolic/nuclear Fe–S proteins in the presence of a 
sulphurous precursor molecule exported from the mitochondrial matrix to the cytosol 
(see reviews by Lill & Mühlenhoff, 2008; Lill, 2009; Sheftel et al., 2010). Genetic 
and biochemical studies in yeast have shown that up to 20 different proteins 
participate in this highly co-operative biosynthetic process (Table 1.2). 
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Table 1.2 Compilation of central components involved in Fe–S protein biogenesis in yeast. 
Protein Full name Proposed function Cellular location 
Nfs1 NifS-like protein 1 
Cysteine desulphurase; 
provides sulphur for Fe–S 
cluster assembly 
Mitochondrial 
matrix, nucleus 
Isd11 
Iron–sulphur cluster assembly 
desulphurase-interacting 
protein 
Serves as an adaptor and 
stabiliser of Nfs1 
Mitochondrial matrix 
Isu1,   
Isu2 
IscU-like proteins 1 and 2 
Serve as molecular scaffolds 
for Fe–S cluster assembly 
Mitochondrial matrix 
Nfu1 NifU-like protein 1 
May serve as an alternative 
scaffold  
Mitochondrial matrix 
Yfh1 Yeast frataxin homologue 1 
Provides iron for Fe–S cluster 
assembly 
Mitochondrial matrix 
Yah1 
Yeast adrenodoxin 
homologue 1 
Provides electrons for the 
reduction of sulphur to sulphide 
Mitochondrial matrix 
Arh1 
Adrenodoxin reductase 
homologue 1 
Provides electrons for the 
reduction of sulphur to sulphide 
Mitochondrial matrix 
Ssq1 Stress-seventy Q protein 1 
ATP-dependent chaperone; 
facilitates Fe–S cluster delivery 
to recipient apoproteins 
Mitochondrial matrix 
Jac1 J-type accessory chaperone 1 
Co-chaperone; stimulates the 
ATPase function of Ssq1 
Mitochondrial matrix 
Mge1 
Mitochondrial GrpE  
homologue 1 
Exchanges Ssq1-bound ADP 
for ATP to initiate a new cycle 
Mitochondrial matrix 
Grx5 Glutaredoxin 5 
Facilitates Fe–S cluster 
delivery to recipient 
apoproteins 
Mitochondrial matrix 
Atm1 
Mitochondrial ABC 
transporter protein 1 
Exports a sulphurous precursor 
molecule to the cytosol 
Mitochondrial inner 
membrane 
Erv1 
Essential-for-respiration-and-
vegetative-growth protein 1 
Sulphydryl oxidase; facilitates 
the export of the precursor 
molecule 
Mitochondrial 
intermembrane space 
Cfd1 
Cytosolic Fe–S cluster-
deficient protein 1 
Serves as a molecular scaffold 
for Fe–S cluster assembly 
Cytosol 
Nbp35 
Nucleotide-binding protein 
35 
Serves as a molecular scaffold 
for Fe–S cluster assembly 
Cytosol 
Nar1 
Nuclear architecture-related 
protein 1 
Facilitates Fe–S cluster 
delivery to recipient 
apoproteins 
Cytosol 
Cia1 
Cytosolic iron–sulphur 
cluster assembly protein 1 
Facilitates Fe–S cluster 
delivery to recipient 
apoproteins 
Cytosol 
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Another significant finding from genetic and biochemical investigations is that Fe–S 
cluster biogenesis is required for the maintenance of mitochondrial iron homeostasis. 
Yeast strains that are depleted of Fe–S cluster biogenesis proteins (e.g. Nfs1, Isd11, 
Isu1, Isu2, Yfh1, Yah1, Nfu1, Ssq1, and Jac1) exhibit marked iron accumulation in 
their mitochondria. Mitochondrial iron overload is also a characteristic of a subset of 
human diseases which are linked to Fe–S cluster formation (Rouault & Tong, 2008). 
1.4.3 Mechanisms of Fe–S cluster assembly 
It has been known for decades that Fe–S clusters can be synthesised in vitro starting 
with an iron source (Fe
2+
) and elemental sulphur (S
0
) (reviewed by Beinert et al., 
1997). The low solubility of iron and high toxicity of free Fe
2+
, Fe
3+
 and S
2-
 ions 
within the cell, however, have caused organisms to develop salient mechanisms 
which promote: (i) the donation of iron and sulphur in a non-toxic form; (ii) the de 
novo assembly of Fe–S clusters on molecular scaffolds; and (iii) the delivery of pre-
assembled clusters from scaffolds to target apoproteins. 
Functioning of the ISC assembly, ISC export and CIA machineries is central to the 
formation of nascent Fe–S clusters as well as their transfer to recipient apoproteins 
(Figure 1.2). An early crucial reaction in mitochondrial Fe–S cluster assembly is the 
release of sulphur from L-cysteine to yield L-alanine. This reaction is catalysed by a 
two-protein desulphurase complex comprising a pyridoxal-5ʹ-phosphate (PLP)-
dependent cysteine desulphurase, Nfs1, and its 11-kDa functional partner, Isd11. 
Nfs1-bound sulphur is then donated to a pair of scaffold proteins, Isu1 and Isu2, that 
provide a chemically and structurally favourable platform for de novo Fe–S cluster 
biosynthesis. (Given the fact that isu2 originates from a recent duplication of isu1 
and that Isu2 is functionally redundant with Isu1, only Isu1 will be mentioned in the 
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following text.) The transfer of sulphur to the site of Fe–S cluster biosynthesis is 
aided by the transient binding of Nfs1 to Isu1. Electrons, which are required for the 
reduction of S
0
 to S
2-
, are provided by a short electron-transport chain consisting of 
Arh1 (yeast ferredoxin reductase) and Yah1 (yeast ferredoxin). The flow of electrons 
is likely to be coupled to the oxidation of NADH. Fe
2+
, which is pre-imported from 
the cytosol to the mitochondrial matrix in a membrane-potential-dependent manner, 
is donated to Isu1 by Yfh (yeast frataxin). The liberation and subsequent trafficking 
of the Isu1-bound Fe–S cluster (either [2Fe–2S] or [4Fe–4S]) is facilitated by a 
mitochondrial monothiol glutaredoxin, Grx5, and a dedicated chaperone system 
consisting of Ssq1, Jac1 and Mge1. The chaperone system relies on ATP hydrolysis 
for the transfer of the pre-assembled Fe–S cluster to mitochondrial apoproteins. 
Extramitochondrial Fe–S cluster assembly is connected to mitochondrial Fe–S 
cluster assembly via an uncharacterised precursor. A sulphurous compound (which 
may be the pre-assembled Fe–S cluster itself or a modified form of sulphur) is 
exported from the mitochondrial matrix to the cytosol by the action of an ABC-type 
transporter of the mitochondrial inner membrane, Atm1. The export reaction is 
further facilitated by a sulphydryl oxidase, Erv1, localised to the mitochondrial 
intermembrane space. In the cytosol, a transiently bound Fe–S cluster is formed on a 
two-protein scaffold complex comprising P-loop NTPases, Cfd1 and Nbp35. The 
pre-formed Fe–S cluster is then transferred to cytosolic/nuclear apoproteins in a 
reaction involving Nar1 and Cia1 (see reviews by Lill & Mühlenhoff, 2008; Lill, 
2009; Sheftel et al., 2010). 
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Figure 1.2 Working model of Fe–S cluster assembly in yeast. In the mitochondrion, the Nfs1/Isd11 
cysteine desulphurase complex mobilises elemental sulphur required for cluster formation. A nascent 
Fe–S cluster is assembled on the Isu1 scaffold protein, with ferrous iron imported from the cytosol by 
mitoferrins (Mrs3/4) and delivered to Isu1 by Yfh1. A short electron transfer chain, which involves 
NADH, Arh1 and Yah1, provides electrons for the reduction of elemental sulphur to sulphide. A 
chaperone system, which consists of Ssq1–ATP, Jac1 and Mge1, transfers the pre-assembled cluster 
from Isu1 to a mitochondrial apoprotein. Grx5 also participates in this transfer reaction. The ISC 
export machinery, which is comprised of Atm1 and Erv1, exports a precursor molecule (X) produced 
by the ISC assembly machinery to the cytosol. The CIA machinery depends on this molecule to lead 
the maturation of cytosolic/nuclear Fe–S proteins. A transient cluster is formed on the Cfd1/Nbp35 
scaffold complex and subsequently transferred from Cfd1/Nbp35 to recipient apoproteins by Nar1 and 
Cia1.  
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1.5 Human diseases associated with Fe–S cluster assembly 
Several human disorders have been linked to defects in the essential process of Fe–S 
cluster biogenesis. Mutations in certain Fe–S cluster assembly genes either cause a 
loss of function of the corresponding proteins or result in diminished protein 
amounts. For instance, GAA triplet repeat expansion in the first intron of the FXN 
gene (which encodes frataxin) is the most frequent mutation encountered in 
Friedreich‟s ataxia (FRDA), an autosomal recessive neurodegenerative disease. 
FRDA is the most common manifestation of hereditary ataxia in humans and occurs 
due to a functional deficiency in frataxin. In FRDA patients, sensory neurons and 
cardiac myocytes are adversely affected. The diseased cells are known to exhibit 
deficiencies in the mitochondrial Fe–S proteins aconitase and complex I–III and 
sequester iron in mitochondria. The very characteristic of iron as an outstanding 
biological catalyst also results in the generation of highly toxic hydroxyl radicals via 
the Fenton reaction, reflecting the double-edged role of this metal in the cell. Other 
diseases associated with Fe–S cluster assembly are: ISCU-deficient myopathy with 
exercise intolerance, appearing in skeletal and cardiac myocytes; GLRX5-deficient 
microcytic anaemia, appearing in developing red blood cells; ABCB7-deficient 
XLSA/A (X-linked sideroblastic anaemia with ataxia), appearing in developing red 
blood cells and cerebellar neurons; and GFER-deficient myopathy with combined 
respiratory-chain deficiency, appearing in skeletal myocytes. (ABCB7 is the human 
Atm1 orthologue; GFER is the human Erv1 orthologue.) On the basis of the fact that 
defects in a ubiquitous biosynthetic pathway are responsible for diverse disease 
presentations in different tissues ranging from nerve to muscle to blood, it is likely 
that mutations in several other Fe–S cluster assembly genes may account for diseases 
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of which the definite etiology has not been elucidated yet (see reviews by Rouault & 
Tong, 2008; Sheftel & Rill, 2009; Sheftel et al., 2010; Ye & Rouault, 2010). 
1.6 Nfs1: the NifS-like cysteine desulphurase of eukaryotes 
Nfs1 is a pyridoxal-5ʹ-phosphate (PLP)-dependent cysteine desulphurase belonging 
to the class V aminotransferase family of proteins (Pfam entry PF00266). The 
corresponding open reading frame (YCL017c) was first discovered when the entire 
DNA sequence of S. cerevisiae chromosome III was determined (Oliver et al., 1992).  
The gene product was named Nfs1 for bearing a certain degree of sequence identity 
to NifS of nitrogen-fixing bacteria. 
Only some time after the identification of a NifS-like protein in a eukaryote did 
researchers reveal that NifS from A. vinelandii was a PLP-containing homodimer and 
catalysed the conversion of L-cysteine into L-alanine, sequestering the released 
sulphur atom in the form of a protein-bound persulphide on a conserved cysteine 
residue (Zheng et al., 1993; Zheng et al., 1994). The same mechanism was 
subsequently described for IscS, another NifS-like protein, from E. coli (Flint, 1996). 
The ability of NifS-like proteins to mobilise sulphur as well as their presence in other 
organisms than nitrogen-fixing bacteria raised the possibility that NifS-like proteins 
might play a global role in Fe–S cluster biosynthesis. Now, it is known that all 
organisms encode NifS-like proteins (termed NifS, IscS, CsdA, or SufS in 
prokaryotes, depending on the operon in which they reside; termed Nfs1 in 
eukaryotes). Nfs1 shows the highest degree of similarity to IscS, which has a general 
housekeeping role in the formation of Fe–S clusters. NifS is responsible only for the 
maturation of the Fe–S protein nitrogenase and cannot replace IscS in A. vinelandii 
(Johnson et al., 2005b). An exceptional group of eukaryotes with regard to the 
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housekeeping nature of the ISC system seem to be Amoebozoa, which possess the 
elements of the NIF system (Ali et al., 2004; van der Giezen et al., 2004; Gill et al., 
2007). This blurs the clear separation between these systems and provides evidence 
for their interchangeability. 
Some organisms, such as E. coli, possess multiple NifS-like proteins (IscS, CsdA and 
SufS), whereas the yeast and human genomes encode only a single NifS-like protein 
(Nfs1/NFS1). Yeast Nfs1 was demonstrated to be an essential Fe–S cluster assembly 
protein localising to mitochondria (Kispal et al., 1999; Li et al., 1999; Mühlenhoff et 
al., 2004). However, identification of a potential nuclear localisation signal sequence, 
RRRPR, in the predicted mature form of yeast Nfs1 raised the possibility that the 
protein might also present in a different subcellular location (Nakai et al., 2001). 
Recent work provided direct evidence that yeast Nfs1 was found at very low levels in 
the nucleus and that the mitochondrial and nuclear isoforms of Nfs1 were derived 
from a single translation product (Naamati et al., 2009). Although human NFS1 was 
also shown to localise to different subcellular compartments (mitochondria, cytosol 
and nucleus), this distribution was claimed to occur via alternative translation 
initiation (Land & Rouault, 1998). The existence of distinct isoforms within the cell 
may reflect the involvement of Nfs1 in general sulphur trafficking as well as Fe–S 
cluster formation (see Section 1.6.3). 
In addition to its pivotal role in the mobilisation and trafficking of sulphur, Nfs1 was 
also shown to exert regulatory effects on cellular iron metabolism (Li et al., 1999). 
These effects, resulting from lowered Nfs1 amounts, include the up-regulation of 
cellular iron uptake and occurrence of mitochondrial iron overload. 
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1.6.1 Related structures 
NifS from the hypertermophilic bacterium Thermotaga maritima was the first NifS-
like protein of which the crystal structure was reported to a resolution of 2.0 Å 
(Kaiser et al., 2000). T. maritima NifS (PDB entry 1ECX) is a dimer of two identical 
subunits, each of which is divided into a small and a large domain. The active site 
lies close to the surface near the dimer interface and harbours the PLP co-factor 
attached to a conserved lysine (Lys203) at the base of a pocket. The catalytic 
cysteine (Cys324) resides in the middle of a 12-residue-long highly flexible loop. 
Stacking on top of PLP is a conserved histidine (His99) which is proposed to serve as 
an acid/base catalyst during the reaction. 
The crystal structure of T. maritima NifS was followed by the crystal structure of 
IscS from E. coli to a resolution of 2.1 Å (Cupp-Vickery et al., 2003). Despite the 
fact that E. coli IscS shows only 39% sequence identity with T. maritima NifS, the 
overall topology of E. coli IscS (PDB entry 1P3W) is virtually the same as that of T. 
maritima NifS, with nearly identical secondary structural elements (Figure 1.3). In E. 
coli IscS, however, the peptide loop accommodating the catalytic cysteine (Cys328) 
is ordered to a certain extent. E. coli IscS exhibits a significant degree of similarity to 
NifS-like enzymes from higher organisms (56% sequence identity with yeast Nfs1; 
59% sequence identity with human NFS1), providing a good model for eukaryotic 
cysteine desulphurases. 
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Figure 1.3 Ribbon structure of E. coli IscS homodimer (PDB entry 3LVM), seen looking down the 
two-fold axis. A greater portion of the peptide backbone adopts an α-helical conformation. The two 
subunits are shown in blue and green. This figure was generated using PyMOL 
(http://www.pymol.org). 
In another success story, crystal structures of E. coli IscS bound to the sulphur-
acceptor proteins TusA and IscU (PDB entries 3LVJ, 3LVK and 3LVL) disclosed 
distinct docking sites for the different binding partners, all accepting sulphur from 
the same catalytic residue (Shi et al., 2010). Structures of the IscS/TusA and 
IscS/IscU complexes showed that the sulphur-accepting proteins TusA and IscU 
approach Cys328 from different directions, implying that the conformational 
plasticity of the long loop accommodating this active-site cysteinyl residue is crucial 
for IscS to effectively deliver its sulphur cargo to multiple recipient proteins. 
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1.6.2 Reaction mechanism 
Dean and co-workers were the first to characterise the mechanism for the 
desulphuration of L-cysteine catalysed by a NifS-like enzyme (Zheng et al., 1994). 
Because the catalytic activity of A. vinelandii NifS was greatly sensitive to thiol-
alkylating agents, a reactive cysteinyl residue was proposed to be engaged in 
catalysis. They also suggested that the Fe–S cluster assembly process was driven by 
a NifS-bound cysteinyl persulphide intermediate, which could be formed through 
nucleophilic attack by the catalytic cysteinyl thiolate on the L-cysteine–PLP adduct. 
In the light of crystal structures available for A. vinelandii NifS and E. coli IscS, it is 
now known that NifS-like enzymes are composed of two identical subunits, each 
harbouring a PLP molecule covalently attached to a conserved active-site lysinyl 
residue by an imine linkage (internal aldimine) in the resting state (Kaiser et al., 
2000; Cupp-Vickery et al., 2003). The catalytic cycle is initiated upon binding of the 
amino acid substrate, L-cysteine, to form a Michaelis complex. A conserved 
histidinyl resiude, which is positioned directly on top of the PLP co-factor, is 
believed to deprotonate the α-amino group of L-cysteine. The deprotonated substrate 
performs a nucleophilic attack on C4ʹ of PLP, releasing the ε-amino group of lysine 
and forming a new imine bond with PLP (external aldimine). The external aldimine 
is formed via the intermediacy of a transient geminal-diamine. The active-site lysinyl 
residue abstracts the C
α
 proton of the substrate to yield a substrate–PLP quinonoid 
adduct. Reprotonation of the quinonoid intermediate results in a substrate–PLP 
ketimine adduct, on which the reactive cysteine thiolate performs a nucleophilic 
attack to cleave the C–S bond and form the enzyme-bound cysteinyl persulphide 
intermediate (Cys–S–SH) and an enamine derivative of L–alanine (Figure 1.4). 
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Figure 1.4 Proposed mechanism for the cysteine desulphuration reaction catalysed by NifS-like 
enzymes. The reaction simply involves formation of an L-cysteine–PLP ketimine adduct, with 
subsequent nucleophilic attack by the thiolate anion of the active-site cysteinyl residue on the sulphur 
atom of the PLP-activated cysteine substrate. An enzyme-bound persulphide intermediate is 
eventually generated, forming the basis of sulphur transfer to recipient proteins (e.g., U-type scaffold 
proteins, as in the case of Fe–S cluster assembly). The L-cysteine–PLP ketimine adduct is shown in a 
red rectangular box. This figure was prepared using ChemDraw (http://www.cambridgesoft.com/). 
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1.6.3 Other reactions 
To date, numerous reports have documented the role of IscS in Fe–S cluster 
assembly. IscS interacts with IscU, which is the primary scaffold for the biosynthesis 
of the [2Fe–2S] and [4Fe–4S] clusters, to deliver sulphur. In fact, this versatile 
enzyme can interact with several other acceptor proteins (e.g., ThiI, TusA and 
MoaD/MoeB) through a broad docking surface centred on Cys328, transferring 
sulphur to different metabolic pathways including the biosynthesis of thiamine and 
biotin, thiolation of tRNAs, and biosynthesis of the molybdenum co-factor (Moco) 
(Shi et al., 2010). 
In analogy with the bacterial system, yeast Nfs1 (Nakai et al., 2004) and 
Trypanosoma brucei Nfs1 (Paris et al., 2010) were shown to be involved in the post-
transcriptional thio-modification of both mitochondrial and cytosolic tRNAs in vivo. 
What is more, the cytosolic isoform of human NFS1 was demonstrated to act as a 
sulphur donor for Moco formation in vitro, bearing functional resemblance to its 
bacterial orthologue (Marelja et al., 2008). 
1.7 Isd11: the ISC assembly desulphurase-interacting protein 
Until recently, Nfs1 was thought to catalyse sulphur transfer to the Isu1 scaffold 
protein by itself. This, however, was disproved by two independent groups of 
workers who reported that S. cerevisiae Nfs1 required binding of a small (11 kDa) 
protein called Isd11 to fulfil its regular function (Adam et al., 2006; Wiedemann et 
al., 2006). They found that Isd11 was an essential protein of the mitochondrial 
matrix, loosely associated  with the mitochondrial inner membrane. Although 
isolated Nfs1 exhibited enzymatic activity as a cysteine desulphurase and released 
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sulphide from cysteine in vitro, the Nfs1/Isd11 complex (which was estimated to be 
190 ± 10 kDa in size) is the active sulphur donor in vivo. Isd11, therefore, was 
suggested to act as a stabiliser of Nfs1. Further studies revealed that Isd11 transiently 
bound to the proposed iron donor Yfh1 (frataxin) both in vitro and in vivo, 
suggesting that the interaction of frataxin with the Nfs1/Isu1 scaffold complex was 
mediated by Isd11 (Shan et al., 2007; Li et al., 2009). 
Isd11 belongs to the LYR family of proteins (Pfam entry PF05347), which is named 
for the presence of a conserved leucine–tyrosine–arginine tripeptide motif near the 
N-terminus. The corresponding open reading frame (YER048w-a) resides on yeast 
chromosome V. Comparative analysis of sequenced genomes uncovered that Isd11 
was exclusive to eukaryotes including mitosomal and hydrogenosomal lineages 
(Richards & van der Giezen, 2006). The absence of Isd11 in currently available 
prokaryotic genomes directly implies that Isd11 is a eukaryotic supplement to the 
bacterium-derived ISC assembly apparatus. In fact, mitosomal localisation and 
functionality of the Nfs1/Isd11 complex from the microsporidians Encephalitozoon 
cuniculi and Trachipleistophora hominis was verified experimentally (Goldberg et 
al., 2008). Direct evidence regarding the localisation and metabolic function of 
microsporidian Fe–S cluster assembly proteins indicates an essential role for the 
mitosome in the biosynthesis of Fe–S proteins.  
Unlike yeast Isd11, which could not be detected in the cytosol and nucleus of yeast 
cells, endogenous ISD11 was shown to be targeted to both the mitochondrial and 
nuclear compartments in human cells (Shi et al., 2009). Given its co-localisation and 
tight association with Nfs1, one would expect Isd11 to be essential for tRNA 
thiolation. Very recently, Isd11 from Trypanosoma brucei was demonstrated to be 
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indispensable for the thiolation of cytosolic and mitochondrial tRNAs (Paris et al., 
2010). 
In addition to their central role in Fe–S cluster assembly, both Isd11 and ISD11 also 
seem to be responsible for the regulation of normal cellular iron levels (Adam et al., 
2006; Shi et al., 2009). This makes ISD11 a potential candidate protein for disease 
pathology. 
1.8 Nfs1/Isd11: the functional desulphurase complex 
As mentioned previously in Section 1.4.3, the biosynthesis of nascent Fe–S clusters 
on Isu1 critically depends on the action of the mitochondrial Nfs1/Isd11 cysteine 
desulphurase complex. Native Nfs1/Isd11 is estimated to be about 190 kDa in size, 
with no clue as to its subunit stoichiometry (Adam et al., 2006). Although Nfs1 is a 
well-known ISC-assembly protein, its 11-kDa binding partner Isd11 is a recently 
identified member of the same subset of proteins and its exact function remains to be 
characterised. 
The presence of mitochondrial-type proteins, such as the ISC-assembly proteins, and 
residual organelles corresponding to mitochondria in microsporidia and other 
supposedly amitochondriates falsifies the central prediction of the „Archezoa‟ 
hypothesis (which simply states that organisms such as Giardia sp., Trichomonas sp., 
and microsporidia have arisen before the establishment of the mitochondrion in the 
eukaryotic lineage). The evolution of the Nfs1/Isd11 protein complex among 
eukaryal groups stands for a latter-day evidence for the universality of mitochondria 
in formerly unknown manifestations. Furthermore, the eukaryotic invention of Isd11 
as a functional partner to Nfs1 directly indicates a single shared α-proteobacterial 
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endosymbiotic origin for today‟s eukaryotes (Richards & van der Giezen, 2006). 
This places α-proteobacterial endosymbiosis before the last common ancestor of all 
eukaryotes in the evolutionary chronology. 
1.9 Summary 
Small inorganic constructs of alternating ferrous/ferric iron and sulphide ions, so-
called Fe–S clusters, are probably nature‟s most ancient prosthetic groups. In 
eukaryotes, these multipurpose reactive centres are assembled by a proteinaceous 
machinery known as the ISC assembly machinery. The ISC assembly machinery is 
primarily localised in mitochondria, establishing the essential role of this organelle in 
Fe–S cluster assembly and providing new insights into human diseases linked to 
impaired Fe–S cluster formation and mitochondrial iron overload. High conservation 
of the ISC assembly machinery in prokaryotes, as well as in eukaryotes, reflects its 
aboriginal and indispensable function and serves as an effective means of tracing 
endosymbiotic evolutionary history. The Nfs1/Isd11 cysteine desulphurase complex, 
which allows for the mobilisation of organic sulphur, is one of the central 
components of the eukaryotic ISC assembly machinery. A thorough characterisation 
of Nfs1/Isd11 should prove useful for a better understanding of the molecular 
mechanisms underlying Fe–S cluster assembly, or intracellular sulphur trafficking in 
general, and associated processes. 
1.10 Aims 
This study aims to produce and characterise a key component, named the Nfs1/Isd11 
cysteine desulphurase complex, of the eukaryotic Fe–S cluster assembly system, 
using advanced laboratory techniques. The architecture of the Nfs1/Isd11 protein 
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complex and the specific interaction between its constituent subunits are the main 
issues to be addressed here. 
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Chapter 2:   Materials and methods 
2.1 PCR amplification of genes 
The polymerase chain reaction (PCR) relies on the general principle of primer-
directed DNA synthesis by DNA polymerases. It expands this process in a cyclical 
series of reactions as the DNA polymerase involved is thermostable and withstands 
repeated cycles of denaturing temperature. Each cycle of PCR comprises steps for 
template denaturation, primer annealing and primer extension. The reaction is 
automated; a thermal cycler is used to programme the temperatures and times for a 
given PCR application. In the present study, S. cerevisiae genomic DNA was used as 
a template for the PCR amplification of the target genes nfs1 and isd11 with gene-
specific primers and the PfuUltra II Fusion HS DNA Polymerase. 
Primer design is the key to the generation of DNA fragments of desired length and 
with tailored ends. Given that Nfs1 and Isd11 localise to the mitochondrion, they are 
expected to carry an N-terminal mitochondrial signal sequence, which directs the 
proteins to the organelle. Since mature proteins lack this internal targeting 
information, it is essential to remove the portion of nucleotides encoding the signal 
sequence before the cloning step. In addition to this, it is also crucial to incorporate 
specific restriction sites at both ends of the PCR product, allowing it to be cloned 
into a vector with compatible sites. MitoProt (http://ihg2.helmholtz-
muenchen.de/ihg/mitoprot.html) predicted that the first 34 amino acid residues of 
Nfs1 (which corresponds to the first 102 nucleotides of nfs1) as well as the first 10 
amino acid residues of Isd11 (which corresponds to the first 30 nucleotides of isd11) 
represent the mitochondrial signal sequence. Therefore, PCR primers were designed 
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in accordance with the MitoProt results as well as the vector preferences (Table 2.1). 
Primer synthesis was achieved externally by Eurofins MWG Operon. 
Table 2.1 Gene-specific oligonucleotide primers used in this study. (Uppercase letters: 
complementary sequence; lowercase letters: newly introduced sequence; yellow highlight: NdeI 
restriction site; bright green highlight: BamHI restriction site; turquoise highlight: XhoI restriction 
site; pink highlight: NotI restriction site; underlined letters: hexahistidine-tag-coding sequence) 
Primer set                                                         
(5′→3′) 
Amplification 
product 
Translation 
product 
Forward: aga aga cat atg TCC CCT CCT GCA GCA 
GGC GTG AAG TTA GAC G 
Reverse: tct tct gga tcc TCA ATG ACC TGA CCA 
TTT GAT GGA GTT TAA G 
nfs1Δ1–102 Nfs1Δ1–34 
Forward: aga aga cat atg CAG GTG TTG TCT TTA 
TAC AAG G 
Reverse: tct tct gga tcc TTA GTG TTT TCT TCC 
TTG CAA TGG 
isd11Δ1–30 Isd11Δ1–10 
Forward: aga aga cat atg CCC ATA TAT CTT GAC 
ATG CAA GCC ACT ACA CC 
Reverse: tct tct gga tcc TCA ATG ACC TGA CCA 
TTT GAT GGA GTT TAA G 
nfs1Δ1–294 Nfs1Δ1–98 
Forward: aga aga cat atg cat cac cat cac cat cac TCC 
CCT CCT GCA GCA GGC GTG AAG TTA GAC G 
Reverse: tct tct ctc gag TCA ATG ACC TGA CCA 
TTT GAT GGA GTT TAA G 
nfs1Δ1–102 Nfs1Δ1–34 
Forward: aga aga gga tcc g CAG GTG TTG TCT 
TTA TAC AAG G 
Reverse: tct tct gcg gcc gc TTA GTG TTT TCT TCC 
TTG CAA TGG 
isd11Δ1–30 Isd11Δ1–10 
 
2.1.1 Materials 
Reagents 
 PfuUltra II Fusion HS DNA Polymerase and 10× PfuUltra II Reaction Buffer 
(both Stratagene) 
 „Long Range‟ dNTP-Mix, each dNTP at 10 mM (Bioline) 
 Gene-specific oligonucleotide primers (see Table 2.1 for details) 
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 S. cerevisiae genomic DNA, at 100 ng μl-1 
 peqGOLD Universal Agarose (Peqlab) 
 1× Tris–acetate–EDTA (TAE) buffer: 40 mM Tris, 20 mM acetic acid, 1 mM 
EDTA 
 Ethidium bromide solution, at 10 mg ml-1 (Fisher Scientific) 
 5× DNA Loading Buffer (Bioline) 
 DNA HyperLadder I (Bioline) 
 QIAprep Gel Extraction Kit (Qiagen) 
Equipment and instruments 
 Agarose gel electrophoresis apparatus 
 Thermal cycler 
 Microcentrifuge 
2.1.2 Reaction mixture 
The PCR reagents were mixed in appropriate amounts in thin-walled PCR tubes that 
were kept on ice throughout the preparation period (Table 2.2). 
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Table 2.2 PCR mixture. 
Reagent Amount 
PfuUltra II Reaction Buffer (10) 5 μl 
„Long Range‟ dNTP-Mix (10 mM each dNTP) 2 μl 
S. cerevisiae genomic DNA (100 ng μl-1) 1 μl 
Forward primer (10 μM) 1 μl 
Reverse primer (10 μM) 1 μl 
Distilled water 39 μl 
PfuUltra II Fusion HS DNA Polymerase 1 μl 
 
Total reaction volume 
 
50 μl 
 
2.1.3 Thermal cycling conditions 
Thermal cycler was programmed using the recommended cycling parameters for the 
PfuUltra II Fusion HS DNA Polymerase (Table 2.3). „Hot lid‟ option was chosen in 
order to prevent evaporation. 
Table 2.3 Thermal cycling conditions. (a: optimised for the target isd11Δ1–30; b: optimised for the 
targets nfs1Δ1–102 and nfs1Δ1–294) 
Segment No. of cycles Temperature Duration 
1 1 95 °C 2 min 
2 30 
95 °C 20 s 
60 °C 20 s 
72 °C 15 sa or 1 min 15 sb 
3 1 72 °C 3 min 
4 1 4 °C ∞ 
 
2.1.4 Agarose gel electrophoresis and gel-purification of PCR products 
The principle of agarose gel electrophoresis is the separation of DNA molecules 
according to conformation and size by their movement through a defined-percentage 
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agarose gel under the influence of an electric field. Here, agarose gel electrophoresis 
of DNA was used to assess the success of the amplification reaction as well as to 
isolate the PCR product from the reaction mixture. 
A 1% (w/v) horizontal agarose gel, supplemented with 0.5 μl ethidium bromide per 
100 ml gel, was prepared. 50 μl of PCR mixture was mixed with 12.5 μl of             
5× agarose gel loading dye, and the resulting sample was loaded in roughly equal 
amounts to multiple wells of the agarose gel submerged in 1× TAE buffer. The gel 
was run at 75 V until the tracking dye migrated about one third of the gel. The bands 
corresponding to the PCR product to be cloned were excised on a UV illuminator 
using a clean scalpel. The resulting pieces of agarose containing the PCR product 
were treated with the QIAquick Gel Extraction Kit according to the manufacturer‟s 
instructions. The clean PCR product was eluted in 50 μl of Qiagen‟s elution buffer. 
The purified PCR product was either stored at -20 °C or directly used in subsequent 
cloning reactions. 
2.2 Directional cloning of PCR products 
Gene cloning is the process of constructing and propagating recombinant DNA 
molecules. The activity of commercially available enzymes (restriction 
endonucleases and the T4 DNA ligase) to manipulate DNA is central to gene 
cloning. The PCR product and the vector are cut in a double-digest experiment with 
the same pair of restriction endonucleases to yield cohesive ends for ligation. 
Covalent linkage of pieces of DNA and formation of closed circular DNA permit 
subsequent transformation reactions to occur efficiently. Transformation is simply 
the introduction of recombinant plasmid DNA constructs into host cells that are 
rendered competent to enable effective uptake of plasmids. 
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2.2.1 Materials 
Reagents 
 Expression vectors: pET-14b, pET-3a and pCDFDuet-1 (all Novagen) 
 Restriction endonucleases: NdeI, BamHI, XhoI and NotI (all New England 
Biolabs) 
 10× reaction buffers: NEBuffer 3 and NEBuffer 4 (both New England Biolabs) 
 Bovine serum albumin, at 10 mg ml-1 (New England Biolabs) 
 DNA Ligation Kit (Takara) 
 α-Select Chemically Competent Cells (Bioline) 
 SOC medium: 2% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.4% (w/v) glucose, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 
 LB broth, Lennox: 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl 
 LB–agar, Lennox: 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 
1.5% (w/v) agar 
 Selective antibiotics: ampicillin and streptomycin (both Sigma-Aldrich) 
 QIAquick Spin Miniprep Kit (Qiagen) 
 DNA sequencing primer: ACYCDuetUP1 Primer (Novagen) 
Equipment and instruments 
 Temperature-controlled water bath 
 Temperature-controlled incubator 
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 Temperature-controlled shaking incubator 
 Microcentrifuge 
2.2.2 Double digestion and clean-up of DNA 
The insert was prepared by double digesting the PCR product with appropriate 
restriction endonucleases. Each corresponding vector (see Appendix for details) was 
also double digested with the same set of restriction endonucleases (Table 2.4). New 
England Biolabs‟ Double Digest Calculator programme (http://www.neb.com/ 
nebecomm/DoubleDigestCalculator.asp) was used to determine the double-digest 
conditions (Table 2.5). 
Table 2.4 Restriction enzymes used for the cloning of PCR products into corresponding 
expression vectors. 
PCR product Vector Enzyme set 
nfs1Δ1–102 pET-14b NdeI–BamHI 
isd11Δ1–30 pET-14b NdeI–BamHI 
isd11Δ1–30 pET-3a NdeI–BamHI 
nfs1Δ1–292 pET-14b NdeI–BamHI 
nfs1Δ1–102 
pCDFDuet-1  
(MCS2) 
NdeI–XhoI 
isd11Δ1–30 
pCDFDuet-1  
(MCS1) 
BamHI–NotI 
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Table 2.5 Double-digest conditions. (c: optimised for the BamHI/NotI and NdeI/BamHI digests;   
d: optimised for the NdeI/XhoI digest) 
Reagent Amount 
Vector or PCR product (400 ng μl-1) 10 μl 
NEBuffer 3c or 4d (10) 10 μl 
Bovine serum albumin (10 mg ml-1) 1 μl 
Distilled water 77 μl 
Restriction endonuclease #1 (10/20 U μl-1) 1 μl 
Restriction endonuclease #2 (10/20 U μl-1) 1 μl 
 
Total reaction volume 
 
100 μl 
 
Each reaction was incubated for 4 h at 37 °C. After the incubation period, both the 
insert and the vector were purified using the specified reagents from the QIAquick 
Gel Extraction Kit. 30 μl of Qiagen‟s elution buffer was used to elute digested DNA. 
The purified digestion product was either stored at -20 °C or directly used in 
subsequent ligation reactions. 
2.2.3 Sticky-end ligation 
Ligation of the insert into the vector was performed using Takara‟s DNA Ligation 
Kit, which involves an optimised buffer system and T4 DNA Ligase. The standard 
protocol was employed for the sticky-end ligation (Table 2.6). 
Table 2.6 Sticky-end ligation reaction mixture. 
Reagent Amount 
Vector DNA 2 μl 
Insert DNA 8 μl 
Ligation Mix 10 μl 
 
Total reaction volume 
 
20 μl 
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Each reaction was incubated for 30 min at 16 °C. Following ligation, the reaction 
mixture was either stored at 4 °C or directly used in subsequent transformation 
reactions. 
2.2.4 Transforming a general subcloning host 
5 μl of the ligation reaction was used to transform 50 μl of E. coli α-Select 
Chemically Competent Cells according to the manufacturer‟s instructions. The 
suggested transformation protocol basically involves a 40-s heat-shock treatment at 
42°C. Transformants were selected for growth by plating the cells on LB–agar 
supplemented with the appropriate antibiotic for the chosen vector (Table 2.7). The 
plates were incubated overnight (16–18 h) at 37 °C. The competent cells provide 
recA1 and endA1 markers to minimise recombination and enhance the quality of the 
construct (see Appendix for details). 
Table 2.7 Names and concentrations of antibiotics used for the selection of expression vectors 
Vector Selective antibiotic Antibiotic concentration 
pET-14b Ampicillin 100 μg ml-1 
pET-3a Ampicillin 100 μg ml-1 
pCDFDuet-1 Streptomycin 50 μg ml-1 
 
2.2.5 Plasmid preparation 
Following overnight incubation at 37 °C, several colonies were picked and each was 
used to inoculate 5 ml of LB containing the appropriate antibiotic. The cultures were 
allowed to grow overnight at 37 °C. Plasmid DNA was isolated from the cultures 
using the QIAquick Spin Miniprep Kit according to the manufacturer‟s instructions. 
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50 μl of Qiagen‟s elution buffer was used to elute DNA. This isolation protocol 
yields plasmid at a concentration of about 400 ng μl-1. 
2.2.6 Custom DNA sequencing 
Bacterial clones were verified for each target via DNA sequencing achieved 
externally by Eurofins MWG Operon. pET-14b- and pET-3a-based constructs were 
sequenced using the T7 Promoter Primer and the T7 Terminator Primer (both 
provided by Eurofins MWG Operon), whereas pCDFDuet-1-based constructs were 
sequenced using the ACYCDuetUP1 Primer and the T7 Terminator Primer. The 
verified plasmids were designated as pKT1 (pET-14b-based construct encoding His6-
tagged Isd11Δ1–10), pKT2 (pET-14-based construct encoding His6-tagged   
Nfs1Δ1–34), pKT3 (pET-14b-based construct encoding His6-Nfs1Δ1–98), pKT4 
(pCDFDuet-1-based construct simultaneously encoding His6-tagged Nfs1Δ1–34 and 
His6-tagged Isd11Δ1–10), and pKT5 (pET-3a-based construct encoding tag-free 
Isd11Δ1–10) (Figure 2.1). 
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Figure 2.1 Representative constructs used in this study. rbs: ribosome-binding site; bla (ApR): 
ampicillin resistance gene; ori: pBR322 origin; lacI: lac repressor gene; aadA (SmR): streptomycin 
resistance gene; CDF ori: CloDF13 origin. 
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1.3 Heterologous production of proteins 
One of the most useful applications of recombinant DNA technology is heterologous 
protein production, which consists of the directed synthesis of large amounts of 
foreign proteins in a host cell such as bacteria or yeast. By far, the most favoured 
host for the heterologous production of proteins is E. coli. The production is achieved 
using a T7 RNA polymerase promoter system. The expression vector (e.g., pET) 
contains a phage T7 RNA polymerase promoter and an E. coli ribosome-binding site 
(RBS), followed by the AUG start codon, a multiple cloning site (MCS), and, finally, 
a T7 transcription terminator. Expression is achieved in a special E. coli strain, a 
λDE3 lysogen, which produces the T7 RNA polymerase upon induction with IPTG, 
a non-metabolisable synthetic analogue of lactose. The enzyme is highly selective 
and efficient, only transcribing from the T7 promoter. The activity of the T7 
promoter may be modulated by a regulatory sequence, such as that from the E. coli 
lac operon. Some vectors, such as the Duet vectors, feature two MCSs each of which 
is preceded by a T7 promoter, a lac operator, and an RBS. They allow for the co-
expression and subsequent complexation of interacting proteins with each other in 
vivo. 
2.3.1 Materials 
Reagents 
 Competent cells: RosettaBlue(DE3)pLysS and RosettaBlue(DE3) (both 
Novagen) 
 Construct DNA: pKT1, pKT2, pKT3, pKT4, and pKT5 (see Section 2.2.6 for 
details) 
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 SOC medium (see Section 2.2.1 for details) 
 LB–agar, Lennox (see Section 2.2.1 for details) 
 Selective antibiotics: ampicillin, streptomycin and chloramphenicol (all Sigma-
Aldrich) 
 LB broth, Lennox (see Section 2.2.1 for details) 
 IPTG (Fisher Scientific) 
 Non-detergent sulfobetaine (NDSB) 201 (Sigma-Aldrich) 
 Pyridoxine HCl (Fluka) and pyridoxal-5ʹ-phosphate (PLP) monohydrate (Acros 
Organics) 
 Lysis buffer, ice-cold: 50 mM KH2PO4, 300 mM NaCl, 5 mM                             
2-mercaptoethanol, 20 mM imidazole, 50 μM PLP, 0.125 mM NDSB-201,     
10% (v/v) glycerol (pH 7.0) 
Equipment and instruments 
 Temperature-controlled water bath 
 Temperature-controlled incubator 
 Temperature-controlled shaking incubator 
 Microcentrifuge 
 Preparative centrifuge 
2.3.2 Transforming a gene expression host 
1 μl of purified plasmid DNA was used to transform 20 μl of RosettaBlue competent 
cells according to the manufacturer‟s instructions. The suggested transformation 
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protocol basically involves a 30-s heat-shock treatment at 42 °C. Transformants were 
selected for growth by plating the cells on LB–agar supplemented with 
chloramphenicol (34 μg ml-1) and the appropriate antibiotic for the plasmid used (i.e., 
either ampicillin or streptomycin). The plates were incubated overnight (16–18 h) at 
37 °C. 
2.3.3 Cell growth 
A single colony from a fresh plate was used to inoculate 20 ml of LB broth 
containing 0.5% (w/v) glucose and the appropriate antibiotics. The cells were 
allowed to grow overnight (16–18 h) at 30 °C with shaking. The starter culture was 
then diluted 1:25 into 500 ml of pre-warmed (37 °C) LB broth supplemented with  
50 μM pyridoxine HCl and the appropriate antibiotics. (The expression was scaled 
up using multiple colonies and repeating the steps above.) The expression culture 
was incubated at 37 °C with shaking until A600 reached 0.6–0.8. 10 μl of the culture 
(which represents non-induced total cell protein fraction) was removed for analysis 
by SDS–polyacrylamide gel electrophoresis (SDS–PAGE). 
2.3.4 IPTG induction 
Gene expression was induced by adding IPTG to the remaining culture, which was 
then incubated for an additional period of time at a pre-determined temperature 
(Table 2.8). 10 μl of the culture (which represents induced total cell protein fraction) 
was removed for analysis by SDS–PAGE. 10 μl of the 2× polyacrylamide gel 
loading buffer was added to both of the 10-μl aliquots of fractions (non-induced and 
induced), and the samples were heated to 95 °C for 10 min. Proteins were analysed 
using standard SDS–PAGE methods to determine expression levels by Coomassie 
staining (see Section 2.4.6 for details). 
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Table 2.8 Induction conditions for the expression constructs used in this study. (c: IPTG 
concentration; t: incubation period; T: incubation temperature) 
Plasmid Host strain c (mM) t (h) T (°C) 
pKT1 RosettaBlue(DE3)pLysS 0.4 2 37 
pKT2 RosettaBlue(DE3)pLysS 0.4 14 25 
pKT3 RosettaBlue(DE3)pLysS 0.4 14 25 
pKT4 RosettaBlue(DE3) 1 14 25 
 
2.3.5 Harvest and storage 
The culture was chilled on ice for several minutes, and the cells were collected by 
centrifuging at 4,000 rpm for 15 min at 4 °C. The resulting supernatant was 
discarded, and the cell pellet was resuspended in 10 ml of ice-cold lysis buffer. 
Resuspended cells were frozen at -80 °C. 
2.3.6 Preparing glycerol stocks of cells 
5 ml of LB broth containing the appropriate antibiotics and 0.5% (w/v) glucose was 
inoculated with an isolated colony from a fresh plate. The cells were incubated with 
vigorous shaking (250 rpm) at 30 °C overnight. 0.1 ml of sterile 80% (v/v) glycerol 
was added to 0.9 ml of the culture, and the mixture was mixed well by vortexing. 
These glycerol–cell stocks were flash-frozen in liquid nitrogen and stored at -80 °C. 
2.4 Purification of His6-tagged proteins 
A crucial step for studying individual proteins is the isolation of the protein of 
interest. Fusing non-disruptive tags in-frame to either terminus of the expression 
product is the preferred method for purifying the protein in a rapid manner. To date, 
hexahistidine (His6) moiety is the most popular tag because of its small size and high 
57 
 
affinity for Ni
2+
 ions, even under denaturing conditions. The His6 moiety can also be 
used as an epitope tag for which commercial monoclonal antibodies are available. 
2.4.1 Materials 
Reagents 
 Lysozyme from chicken egg white (Fluka) 
 DNase I (Roche Applied Science) 
 cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets (Roche Applied 
Science) 
 Ni2+-charged HisTrap HP column, 5 ml (GE Healthcare) 
 Native immobilised metal affinity chromatography (IMAC) binding/wash buffer: 
50 mM KH2PO4, 300 mM NaCl, 5 mM 2-mercaptoethanol, 20 mM imidazole,  
10 μM PLP, 0.125 mM NDSB-201 (pH 7.0) 
 Native IMAC elution buffer: 50 mM KH2PO4, 300 mM NaCl, 5 mM                  
2-mercaptoethanol, 500 mM imidazole, 10 μM PLP, 0.125 mM NDSB-201 (pH 
7.0) 
 Denaturing IMAC binding/wash buffer: 50 mM KH2PO4, 300 mM NaCl, 5 mM 
2-mercaptoethanol, 8 M urea, 20 mM imidazole, 10 μM PLP, 0.125 mM NDSB-
201 (pH 7.0) 
 Denaturing IMAC elution buffer: 50 mM KH2PO4, 300 mM NaCl, 5 mM           
2-mercaptoethanol, 8 M urea, 500 mM imidazole, 10 μM PLP, 0.125 mM 
NDSB-201 (pH 7.0) 
 HiPrep Sephacryl S-200 HR column, 120 ml (GE Healthcare) 
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 Size-exclusion chromatography (SEC) equilibration/elution buffer: 20 mM 
HEPES, 200 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% (v/v) glycerol (pH 7.0) 
 2× polyacrylamide gel loading buffer: 125 mM Tris–HCl (pH 6.8), 4% (w/v) 
SDS, 40% (v/v) glycerol, 0.1% (w/v) bromophenol blue, 5% (v/v)                      
2-mercaptoethanol 
 SeeBlue Plus2 Pre-Stained Standard (Invitrogen) 
 Pre-cast 4–20% Tris–HEPES LongLife iGels (NuSep) 
 1× SDS–PAGE running buffer: 100 mM Tris, 100 mM HEPES, 0.1% (w/v) SDS 
(pH 8.0) 
 Staining solution: 30% (v/v) methanol, 10% (v/v) acetic acid, 0.1% (w/v) 
Coomassie Brilliant Blue R-250 
 Destaining solution: 30% (v/v) methanol, 10% (v/v) acetic acid 
Equipment and instruments 
 Sonicator 
 Microcentrifuge 
 Refrigerated bench centrifuge 
 Refrigerated preparative centrifuge 
 Peristaltic pump 
 ÄKTA FPLC System (GE Healthcare) 
 Vivaspin 20 centrifugal concentrators (Sartorius Stedim) 
 SDS–PAGE apparatus 
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2.4.2 Cell lysis and clarification of lysate 
Resuspended cells were thawed using cold (4 °C) water. Following the addition of 
lysozyme at a final concentration of 1 mg ml
-1
, DNase I at a final concentration of    
5 μg ml-1 and protease inhibitors excluding EDTA, the suspension was incubated at  
4 °C for 30 min. (No exogenous lysozyme was used for the lysis of the 
RosettaBlue(DE3)pLysS host strain, which constitutively expresses T7 lysozyme.) 
For further disruption, the cells were subjected to sonication on ice. The process 
involved six 10-s bursts at 40–50% duty with 10-s cooling periods between each 
burst. The cell debris (and inclusion bodies, if any) was sedimented by centrifuging 
at 15,000 rpm for 30 min at 4 °C. The supernatant (which represents soluble 
cytoplasmic fraction) was transferred into a fresh, pre-chilled tube, and 10 μl of it  
was maintained for analysis by SDS–PAGE. 
2.4.3 Immobilised metal affinity chromatography 
Affinity chromatography takes advantage of a specific intrinsic or extrinsic feature of 
the target protein to isolate it from other (i.e., contaminating) proteins in the sample. 
Immobilised metal affinity chromatography (IMAC) is a special form of affinity 
chromatography in which an immobilised metal ion is used to selectively retain 
proteins by forming a coordinate bond with a given chemical group. Chelating 
Sepharose, when charged with Ni
2+
 ions, selectively adsorbs proteins if complex-
forming amino acid residues, particularly histidine, are exposed on the protein 
surface. For the large-scale purification of soluble His6-tagged proteins, pre-packed 
columns can be used with a syringe, a peristaltic pump or a liquid chromatography 
system. These columns also allow for the purification of insoluble His6-tagged 
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proteins from inclusion bodies when denaturing conditions are applied. His6-tagged 
proteins can be readily desorbed with buffers supplemented with imidazole. 
To purify the soluble yeast Nfs1 protein from E. coli proteins under native 
conditions, cleared lysate (approximately 10 ml) was loaded with the aid of a 
peristaltic pump onto a 5-ml HisTrap HP affinity column pre-equilibrated with the 
native IMAC binding/wash buffer. The column was washed with 10 column volumes 
of the same buffer, and the target protein was eluted with 3 column volumes of the 
native IMAC elution buffer. The pump was operated at 4 °C at a constant flow rate 
of  5 ml min
-1
. 
To purify the urea-solubilised yeast Isd11 protein (see Section 2.5.2 for details) from 
E. coli proteins under denaturing conditions, solubilised inclusion body fraction 
(approximately 2.5 ml) was loaded with the aid of a peristaltic pump onto a 5-ml 
HisTrap HP affinity column pre-equilibrated with the denaturing IMAC 
binding/wash buffer. The column was washed with 10 column volumes of the same 
buffer, and the target protein was eluted with 3 column volumes of the denaturing 
IMAC elution buffer. The pump was operated at room temperature at a constant flow 
rate of 5 ml min
-1
. 
2.4.4 Concentrating/buffer-exchanging proteins by centrifugal ultrafiltration 
To concentrate the protein of interest, the most appropriate molecular weight cut-off 
(MWCO) should be selected. Solutions of Nfs1Δ1–34, Nfs1Δ1–98 and the   
Nfs1Δ1–34/Isd11Δ1–10 complex were all applied to Vivaspin 20 10,000 MWCO 
concentrators. Solutions of urea-solubilised Isd11Δ1–10 and refolded Isd11Δ1–10 
were applied to Vivaspin 20 3,000 MWCO concentrators. Assembled concentrators 
were centrifuged at speeds recommended by the manufacturer until the desired 
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protein concentration was reached. The protein sample was recovered from the 
bottom of the concentrate pocket with a pipette. 
Buffer-exchange was also achieved using the corresponding 10,000 and              
3,000 MWCO concentrators. Once the sample was concentrated to the desired level, 
the filtrate container was emptied and the concentrator was refilled with an 
appropriate buffer. The sample was concentrated three more times with this new 
buffer. 
2.4.5 Size-exclusion chromatography 
Size-exclusion chromatography (SEC) is a straightforward and reliable technique for 
separating proteins according to size as they pass through a porous medium. It can 
also be used to determine the relative molecular mass (Mr) of proteins by comparing 
an elution volume parameter, such as Kav of the protein of interest, with the values 
acquired for several known calibration standards. Kav is calculated from the equation 
    
     
     
 
where Ve is the volume in which the standard protein elutes, Vo is the column void 
volume, and Vt is the total bed volume. 
The IMAC eluate fractions containing Nfs1Δ1–34, Nfs1Δ1–98 or the            
Nfs1Δ1–34/Isd11Δ1–10 complex were concentrated to 5 ml using Vivaspin 
centrifugal filter devices (see Section 2.4.4 for details), cleared by microcentrifuging 
at maximum speed for 10 min, and loaded onto a 120-ml HiPrep Sephacryl S-200 
HR column pre-equilibrated with the SEC equilibration/elution buffer. The column 
was washed with 1 column volume of the same buffer, and the SEC eluate fractions 
were collected in 5-ml aliquots. SEC was performed on the ÄKTA FPLC system at  
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4 °C at a constant flow rate of 0.5 ml min
-1
. The SEC peak protein fractions were 
pooled, concentrated to 2 mg ml
-1
 using Vivaspin devices, and stored at 4 °C. Protein 
analysis was achieved by SDS–PAGE. 
2.4.6 SDS–polyacrylamide gel electrophoresis of proteins 
SDS–polyacrylamide gel electrophoresis (SDS–PAGE) is a technique employed to 
analyse and fractionate small amounts of protein. It makes use of SDS to solubilise 
proteins by coating them with a uniform negative charge. SDS treatment greatly 
reduces differences in both charge and conformation between proteins, making size 
the major determinant of electrophoretic mobility. This is the basis for employing 
SDS–PAGE to estimate the molecular weight of the protein of interest with reference 
to the electrophoretic mobility of standard proteins on the same gel. 
10 μl of each protein sample was mixed with an equal volume of 2× polyacrylamide 
gel loading buffer. The samples were solubilised by heating for 5 min at 95 °C and 
clarified by centrifuging at 13,000 rpm for 1 min. 10–20 μl of the supernatant was 
applied per well onto a pre-cast 4–20% Tris–HEPES gel, and the gel was run in the 
SDS–PAGE running buffer at 150 V until the dye front reached the bottom of the 
gel. The gel was stained overnight in the staining solution and destained in the 
destaining solution. Distilled water containing 5% (v/v) glycerol was used to store 
the gel. 
2.5 Protein refolding 
The expression of foreign genes at high levels in E. coli frequently results in the 
formation of cytoplasmic granules or inclusion bodies composed of insoluble 
aggregates of the produced protein. The advantage of using inclusion bodies is that 
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the protein can be readily purified from inclusion bodies with high level of purity. 
The challenge is recovery of the active protein, which is achieved by solubilisation of 
isolated inclusion bodies with water-soluble chaotropic agents such as guanidine 
hydrochloride or urea followed by protein refolding by removal of the denaturant via 
dilution and buffer exchange by dialysis, diafiltration, or chromatography. 
2.5.1 Materials 
Reagents 
 Ni2+-charged HisTrap HP column, 5 ml (GE Healthcare) 
 Native IMAC binding/wash buffer (see Section 2.4.1 for details) 
 Native IMAC elution buffer (see Section 2.4.1 for details) 
 Stabil-P.A.C (Expedeon) 
 Solubilisation buffer: 50 mM KH2PO4, 300 mM NaCl, 15 mM                            
2-mercaptoethanol, 8 M urea, 0.125 mM NDSB-201 (pH 7.0) 
 Refolding buffer 1: 50 mM KH2PO4, 300 mM NaCl, 5 mM 2-mercaptoethanol, 
0.3 mg ml
-1
 NV10 (pH 7.0) 
 Refolding buffer 2: 50 mM KH2PO4, 300 mM NaCl, 5 mM 2-mercaptoethanol,   
1 M NDSB-201, equimass Nfs1Δ1–34 (pH 7.0) 
Equipment and instruments 
 Refrigerated preparative centrifuge 
 Refrigerated bench centrifuge 
 ÄKTA FPLC System (GE Healthcare) 
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 Vivaspin 20 centrifugal concentrators (Sartorius Stedim) 
2.5.2 Isolation and solubilisation of inclusion bodies 
The pellet containing insoluble Isd11Δ1–10 deposits (inclusion bodies) was washed 
twice in 10 ml of the native IMAC binding/wash buffer to remove loosely attached 
E. coli proteins and lipids. Inclusion bodies were collected by centrifuging at    
15,000 rpm for 30 min at 4 °C. Air-dried inclusion bodies were solubilised in 2.5 ml 
of the solubilisation buffer for 30 min at room temperature. A brief sonication 
treatment could further facilitate the solubilisation process. Following clarification 
by centrifuging at 15,000 rpm for 30 min at 4 °C, the supernatant containing 
solubilised Isd11 was transferred to a clean tube by pouring, avoiding cell debris. 
2.5.3 In vitro refolding strategies 
On-column protein refolding method makes use of the His6 tag to achieve rapid 
renaturation and purification. Solubilised Isd11 was immobilised on a 5-ml HisTrap 
HP column connected to the ÄKTA FPLC system. Gradual refolding of the bound 
protein was performed using a linear urea gradient from 8 M to 0 M (which is 
created by mixing the solubilisation and the native IMAC binding/wash buffers) at 
0.5 ml min
-1
. Elution of the refolded protein (if any) was carried out with 5 column 
volumes of the elution buffer. 
Rapid dilution involves the denatured protein being delivered in a very short time to 
a refolding buffer, rapidly lowering the concentrations of both the protein and the 
denaturant. In this method, 2.5 ml of solubilised Isd11 was added to 200 ml of the 
refolding buffer 1 under vigorous stirring, and the protein was allowed to refold 
overnight at room temperature. The resulting precipitation was clarified by 
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centrifuging at 4,000 rpm for 30 min at 4 °C, and the sample was concentrated using 
Vivaspin 20 3,000 MWCO centrifugal filter devices. Pulsed dilution involves the 
solubilised inclusion bodies being delivered in a dropwise fashion to the refolding 
buffer, ensuring that the concentrations of partially folded intermediates are kept low 
at any instant. In this approach, 250 μl of solubilised Isd11 was added to 200 ml of 
the refolding buffer 2 under vigorous stirring, and the protein was allowed to refold 
for 30 min at 4 °C. This was repeated until the protein sample is all diluted (about 10 
times). Following the removal of precipitates by centrifugation, the sample was 
concentrated using Vivaspin 20 centrifugal filter devices (3,000 MWCO). 
2.6 Analytical ultracentrifugation 
Analytical ultracentrifugation (AUC) basically involves the application of a 
centrifugal force, the real-time observation of the resulting macromolecular spatial 
redistribution, and first-principle-based quantitative analysis of the data. One of the 
most frequently encountered applications of AUC is the determination of relative 
molecular mass of proteins or multiprotein complexes. Sedimentation-equilibrium 
AUC approach utilises rotor speeds of approximately 7,000–8,000 rpm and 
establishes a balance between sedimentation under the influence of centrifugal force 
and diffusion of material in the opposite direction. As a result, a point is reached 
where there is no net migration of solute throughout the length of the analytical cell. 
The molecular weight can then be calculated from the concentration gradient of the 
solute set up from the equation 
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where R is the molar gas constant, T is the absolute temperature in K, ω is the 
angular velocity in radian s
-1
,   is the partial specific volume of the solute, ρ is the 
density of the solvent in g cm
-3
, and c2 and c1 are the concentrations of solute at 
distances r2 and r1, respectively, from the centre of rotation. 
The analytical centrifuge bears close resemblance to a conventional preparative 
centrifuge that is equipped with an optical system (e.g., a UV-visible absorbance 
spectrophotometer) for the observation of the protein distribution in real time during 
the centrifugation. 
2.6.1 Sample 
A fresh preparation of Nfs1/Isd11 in the SEC equilibration/elution buffer was used as 
sample for the sedimentation equilibrium study. 
2.6.2 Procedure 
The protein sample was submitted to my colleague Dr Rebecca Beavil at King‟s 
College London. The experiment was conducted at three different rotor speeds 
(7,000 rpm, 8,500 rpm and 10,000 rpm) at 4 °C in an Optima XL-A analytical 
ultracentrifuge (Beckman Coulter) carrying a standard rotor. AUC parameters (ρ, 
  Nfs1,   Isd11) were computed using the SEDNTERP program 
(http://www.rasmb.bbri.org/software/). Computed molecular mass of each subunit 
was entered manually. Data were fitted using SigmaPlot. 
2.7 Quantitative Western blotting 
Measurements of the relative amounts of different proteins in a sample can be 
achieved by blotting separated proteins from the polyacrylamide gel on to a 
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membrane (i.e., Western blotting) and visualising this blot by several means, 
including the commonly used chemiluminescence and visible fluorescence detection 
methods. A third, and more accurate, detection method makes use of the near-
infrared fluorescence for quantitative analysis. In this method, secondary antibodies 
are labelled with IRDye infrared dyes, and IRDye signals are detected by the 
Odyssey Infrared Imaging System over a broad linear dynamic range. 
2.7.1 Materials 
Reagents 
 Purified Nfs1/Isd11 protein complex 
 2× polyacrylamide gel loading buffer (see Section 2.4.1 for details) 
 SeeBlue Plus2 Pre-Stained Standard (Invitrogen) 
 Pre-cast 4–20% Tris–HEPES LongLife iGels (NuSep) 
 1× SDS–PAGE running buffer (see Section 2.4.1 for details) 
 Hybond-P PVDF Membrane (GE Healthcare) 
 Filter paper (GE Healthcare) 
 Antibodies: His·Tag Monoclonal Antibody, mouse IgG1 (Novagen) and 
IRDye800-conjugated Antibody, anti-mouse IgG (Li-Cor) 
 Transfer buffer, ice-cold: 25 mM Tris, 25 mM Bicine, 10% (v/v) methanol 
 Phosphate-buffered saline (PBS): 10 mM Na–K phosphate buffer, 2.7 mM KCl, 
137 mM NaCl (pH 7.4) 
 Blocking buffer: 3% (w/v) BSA in PBS 
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 Wash buffer: 0.1% (v/v) Tween-20 in PBS 
 Primary-antibody solution: His·Tag Monoclonal Antibody (0.1 μg ml-1) in PBS 
containing 0.25% (w/v) BSA and 1% (v/v) Tween-20 
 Secondary-antibody solution: IRDye800-conjugated Antibody (0.01 μg ml-1) in 
PBS containing 1% (v/v) Tween-20, 0.25% (w/v) BSA and 0.01% (w/v) SDS 
Equipment and instruments 
 SDS–PAGE apparatus 
 Microcentrifuge 
 Electroblotting apparatus 
 Mini rocking shaker 
 Odyssey Infrared Imaging System (Li-Cor) 
2.7.2 SDS–PAGE 
His6-tagged subunits of the Nfs1/Isd11 protein complex were separated using SDS–
PAGE as described in Section 2.4.6. Different from a typical SDS–PAGE 
experiment, only 3 μl of the protein standard was loaded onto the gel, and the 
Coomassie staining was omitted. 
2.7.3 Semi-dry electroblotting 
A sheet of PVDF membrane was cut to size and pre-wetted in absolute methanol for 
10 s, followed by a wash in distilled water for 5 min. The membrane, the gel and the 
filter paper were all soaked in the transfer buffer for 15 min. The electroblotting 
cassette was assembled as follows: 
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Cathode (-) 
Extra-thick filter paper 
SDS–polyacrylamide gel 
PVDF membrane 
Extra-thick filter paper 
Anode (+) 
The proteins were transferred for 30 min at 20 V. Following transfer, the membrane 
was removed from the cassette and rinsed briefly with PBS. The membrane/blot was 
allowed to dry overnight. 
2.7.4 Blocking 
The membrane was pre-wetted in absolute methanol for 10 s, rinsed with distilled 
water and wetted in PBS for 5 min. Non-specific binding sites on the membrane were 
blocked by incubating the membrane with the blocking buffer for 1 h at room 
temperature with gentle shaking. The blocking buffer was decanted and the 
membrane was rinsed briefly with the wash buffer. 
2.7.5 Primary-antibody incubation 
The wash buffer was decanted and the primary-antibody solution was added. The 
blot was incubated with primary antibodies overnight at 4 °C with gentle shaking. 
The primary-antibody solution was decanted, and the membrane was washed 4 times, 
each for 5 min, in excess wash buffer. 
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2.7.6 Secondary-antibody incubation 
The wash buffer was decanted and the secondary-antibody solution was added. The 
membrane was incubated with secondary antibodies for 1 h at room temperature with 
gentle shaking. The incubation was carried out in the dark. Following the secondary-
antibody incubation, the membrane was washed 4 times, each for 5 min, in excess 
wash buffer. 
2.7.7 Colour detection, analysis and interpretation 
The blot was rinsed with PBS to remove residual Tween-20 and directly scanned on 
the Odyssey Infrared Imaging System in the 800-nm fluorescence channel. Visible 
bands were sized and quantified using the Odyssey Software. Sizing and 
quantification data were stored in a data file for further analysis and presentation. 
2.8 Quantitative amino acid analysis 
Quantitative amino acid analysis provides useful information about the accurate 
protein concentration and the molar ratio of amino acids present. One of the standard 
methods for measuring the relative amounts of amino acids in protein hydrolysates 
includes ion-exchange chromatographic separation of individual amino acids, 
followed by ninhydrin derivatisation. However, pre-column modification of amino 
acids and subsequent high resolution of their derivatives by reverse-phase high-
performance liquid chromatography (RP-HPLC) is now the preferred method for 
quantitative amino acid analysis. The derivatisation step incorporates covalently 
bound chromophores, allowing for photometric or fluorometric detection. 
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2.8.1 Sample 
A fresh preparation of Nfs1/Isd11 in 4 mM HEPES, pH 7.0, 40 mM NaCl, 0.2 mM 
DTT, 0.2 mM EDTA, and 1% (v/v) glycerol was used as sample for quantitative 
amino acid analysis. 
2.8.2 Procedure 
The protein sample was sent to the Protein and Nucleic Acid Chemistry Facility at 
the University of Cambridge for standard analysis of protein hydrolysates by ion-
exchange chromatography and post-column ninhydrin derivatisation. 
2.9 UV-visible absorbance spectrophotometry 
The use of the absorption, emission, or scattering of electromagnetic radiation by 
matter (atoms, molecules, ions, or solids) to qualitatively or quantitatively investigate 
the matter or physical processes is called spectroscopy. The interaction of 
electromagnetic radiation with matter results in redirection of radiation and/or 
transitions between the energy levels of the atoms or molecules. The method of UV-
visible absorbance spectrophotometry can be used for the qualitative and quantitative 
estimation of proteins. This method is based on the Beer–Lambert law, and the 
instrument is known as a UV-visible absorbance spectrophotometer. The UV-visible 
absorbance spectrophotometer measures the amount of light that a sample absorbs in 
the UV and visible regions of the electromagnetic spectrum (i.e., from 200 nm to   
750 nm). A certain part of the molecule that independently contributes to individual 
regions of an absorption spectrum is termed a chromophore. 
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2.9.1 Materials 
Reagents 
 Purified proteins: Nfs1Δ1–34 and the Nfs1Δ1–34/Isd11Δ1–10 complex 
 L-cysteine (Sigma-Aldrich) 
Equipment and instruments 
 UVettes, 220–1,600 nm (Eppendorf) 
 U-3010 absorbance spectrophotometer (Hitachi) 
2.9.2 Spectrophotometric determination of protein concentration 
Quantitative estimation of proteins in solution can be performed by making use of 
the fact that the three chromophores in proteins (tryptophan, tyrosine and cystine) 
absorb at 280 nm. Beer–Lambert law states that the absorbance (A) is proportional to 
both the concentration of the absorber and the thickness of the layer, as 
        
where ε is the molar absorbance (or extinction) coefficient for the absorber in         
M
-1
 cm
-1
, c is the concentration of the absorber in M, and l is the pathlength through 
the solution in cm (1 cm for standard cuvettes). For conveniency, ε is replaced by the 
absorbance value for a 0.1% solution measured in a 1-cm cuvette (    
    ). This way 
of expressing the extinction coefficient allows one to report the protein concentration 
in mg ml
-1
. 
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Based upon primary sequence analysis using the ProtParam tool (http://expasy.org/ 
tools/protparam.html), the     
     values were computed to be 0.707 for Nfs1Δ1–34, 
0.772 for Nfs1Δ1–98, and 0.685 for Nfs1Δ1–34/Isd11Δ1–10. 
2.9.3 Obtaining substrate binding spectra 
Substrate binding spectra can be used to investigate the degree of interaction between 
an enzyme and its substrate. Many cofactors of enzymes absorb light in the UV-
visible region of the electromagnetic spectrum. For instance, the PLP cofactor of 
cysteine desulphurases absorbs at 420 nm when it is covalently bound to the enzyme 
through a Schiff base. The binding of free cysteine to the enzyme perturbs the 
spectrum by displacing PLP. Therefore, the activities of cysteine desulphurases can 
be measured spectrophotometrically by following the decrease in A420 as a function 
of time. 
Absorbance spectra of Nfs1Δ1–34 and the Nfs1Δ1–34/Isd11Δ1–10 complex, each in 
the SEC equilibration/elution buffer at a final concentration of 3.65 mg ml
-1
, were 
recorded at room temperature both in the absence and presence of 10 mM free 
cysteine (incubation at 4 °C) with the following settings: 
Scan range  260–500 nm 
Scan speed  1,200 nm min
-1
 
Sampling interval 2 nm 
Slit width  2 nm 
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2.10 Fluorescence spectrophotometry 
Fluorescence is an emission process that involves the transition from a higher to a 
lower energy state within a given molecule. It is measured by detecting this emitted 
radiation rather than absorption. The instrument is known as a fluorescence 
spectrophotometer or a spectrofluorimeter. Because the emission intensity is 
proportional to the concentration of the emitter at low concentrations, fluorescence 
spectrophotometry can be used to quantify the emitting species of the molecule 
(fluorophore). Tryptophan and a few cofactors exhibit this emission phenomenon, 
and their presence allows intrinsic fluorescence to be measured in proteins. The 
binding and release of ligands, at sites close to the fluorophore, give rise to 
alterations in the related fluorescence spectra. Thus, useful information about 
conformational changes and unfolding can be gained. 
2.10.1 Materials 
Reagents 
 Purified proteins: Nfs1Δ1–34 and the Nfs1Δ1–34/Isd11Δ1–10 complex 
Equipment and instruments 
 Fluorescence cuvettes (Kartell) 
 F-2500 fluorescence spectrophotometer (Hitachi) 
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2.10.2 Data collection 
Emission spectra of Nfs1Δ1–34 and the Nfs1Δ1–34/Isd11Δ1–10 complex, each in 
the SEC equilibration/elution buffer at a final concentration of 3.65 mg ml
-1
, were 
recorded at room temperature with the following settings: 
Excitation wavelength 295 nm 
Emission wavelength range 315–400 nm 
Scan speed   1,500 nm min
-1
 
Excitation slit width  10 nm 
Emission slit width  10 nm 
2.11 Far-UV circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy is a technique that measures the difference 
between the molar extinction coefficients for left-handed (L) and right-handed (R) 
circularly polarised light, as 
           (units are M
-1
 cm
-1
) 
ε can be replaced by Δε in the Beer–Lambert equation to derive the difference in 
absorption between L and R components (ΔA), as 
          
Much of the literature makes use of the ellipticity (θ), which is related to ΔA by the 
equation 
              (units are mdeg) 
76 
 
The circular dichroism is observed only for chromophores that are in, or closely 
associated with, an optically asymmetric environment. Near-UV CD spectroscopy 
relies upon the atomic environment and closeness of packing of aromatic residues 
and provides useful information about tertiary structure. Alternatively, the far-UV 
CD signals arise from the transitions of the peptide bond and reflect different types 
of secondary structural features (α-helix, β-sheet, and random coil) present. The near- 
and far-UV CD spectra are measured by a spectropolarimeter. 
2.11.1 Materials 
Reagents 
 Purified proteins: Nfs1Δ1–34 and the Nfs1Δ1–34/Isd11Δ1–10 complex 
Equipment and instruments 
 Quartz cuvettes, 1-mm pathlength 
 Chirascan spectropolarimeter (Applied Photophysics) 
2.11.2 Data collection 
Solutions of  protein (0.02–0.2 mg ml-1) were made in an appropriate buffer. The 
instrument was prepared according to the manufacturer‟s instructions, setting the CD 
parameters as follows: 
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Time per point 2 s 
Wavelength range 185/200–260 nm 
Step size  0.5 nm 
Band width  1 nm 
Repeats   3 times 
First, a spectrum for the buffer was acquired at 25 °C. This was followed by 
collecting CD spectroscopic data 3 times for the protein sample at 25 °C. The spectra 
of the buffer and sample (cumulative average of the 3 repeat scans) were smoothed 
using the software installed on the spectropolarimeter. The smoothed baseline was 
subtracted from the smoothed protein spectrum, yielding the actual spectrum to be 
analysed. 
2.11.3 Data analysis and interpretation 
Although a simple inspection of the far-UV CD spectra may help to compare 
changes in the secondary structure of the individual proteins when they are 
associated in the intact complex, deconvolution of the CD signals using online 
analysis programs at DichroWeb (http://dichroweb.cryst.bbk.ac.uk/html/ 
home.shtml) allows for the estimation of the secondary structure content of the 
proteins. 
2.12 Homology modelling 
Homology modelling predicts the three-dimensional (3D) structure for a protein of 
known sequence (the target sequence) by modelling it on the known 3D structure of 
a protein of related sequence (the template sequence). Usually, this approach is only 
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feasible above approximately 30% similarity. Homology models allow for 
identification of binding sites and provide useful information about molecular 
function, provided the residues of the conserved pocket are intact. 
2.12.1 Template selection 
Based on the primary sequence of Nfs1Δ1–98, proteins with homology and whose 
structures have been solved were identified by performing a BLASTP search against 
NCBI‟s Protein Data Bank proteins database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
2.12.2 Target–template alignment 
Once the template sequence was selected, a multiple sequence alignment of the target 
and template sequences was produced using the ClustalW algorithm 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html), which allowed for manipulation 
of parameters (e.g., gap penalties) to ensure that errors were avoided. 
2.12.3 Model building and inspection 
Model building was achieved using the semi-automated MODELLER program 
(http://www.salilab.org/modeller/), which employs the satisfaction-of-spatial-
restraints method. The quality of the model was checked and confirmed by 
superimposing the model structure on the template structure on PyMol and manually 
inspecting the active site. 
2.13 Protein crystallisation screening 
X-ray crystallography currently is perceived as the most robust tool for determining 
the 3D structure of proteins and protein complexes. The major challenge in the X-ray 
crystallography of proteins remains the preparation of appropriate crystalline samples 
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and, more specifically, the search for optimum crystallisation conditions. A 
reasonable place to start is with a concentrated protein sample (5–20 mg ml-1) and a 
commercially available screening kit containing about 50 different crystallisation 
reagents. Screening kits provide likely precipitants for protein crystallisation and can 
be applied manually or with the automated precision of a liquid-handling robot. 
2.13.1 Materials  
Reagents 
 Purified proteins: Nfs1Δ1–34, Nfs1Δ1–98, and the Nfs1Δ1–34/Isd11Δ1–10 
complex 
 Crystallisation buffer: 10 mM HEPES, 100 mM NaCl, 0.5 mM DTT, 0.5 mM 
EDTA, 2.5% (v/v) glycerol, 100 μM PLP (pH 7.0) 
 Crystallisation screening kits: Crystal Screen, Crystal Screen 2, PEG/Ion Screen 
(all Hampton Research); Structure Screen 1, Structure Screen 2 (both Molecular 
Dimensions) 
Equipment and instruments 
 Plates: 24-well plates or 96-well microplates 
 Covers: siliconised 22-mm-diameter square cover slides or 96-well format 
crystallisation sheets 
 20-ml polypropylene syringe 
 Vacuum grease 
 8-channel pipette 
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 Constant-temperature incubator 
 Microcentrifuge 
 Mosquito Crystal nanoliter liquid handler (TTP LabTech) 
 Light microscope 
2.13.2 Sample preparation 
Proteins, which were pre-purified by sequential steps of affinity and size-exclusion 
chromatographies, were buffer-exchanged into the crystallisation buffer and 
concentrated to 10–20 mg ml-1 using Vivaspin 20 concentrators (10,000 MWCO) 
(see Section 2.4.4 for details). Protein concentrations were determined 
spectrophotometrically (see Section 2.9.2 for details). Any amorphous or particulate 
material was removed by centrifuging at 13,000 rpm for 10 min at 4 °C. 
2.13.3 Screening strategies 
For manual screening of crystallisation conditions, a thin bead of vacuum grease was 
applied with the aid of a syringe to the upper edge of each of the 24 reservoirs.      
600 μl of each reagent from a commercial screen (Crystal Screen, Crystal Screen 2, 
or PEG/Ion Screen) was transferred to multiple 24-well plates, avoiding reagent 
contamination and carry over. 1 μl of the protein sample (Nfs1Δ1–34, Nfs1Δ1–98, or 
the Nfs1Δ1–34/Isd11Δ1–10 complex) was pipetted onto the centre of a clean cover 
slide and subsequently mixed by pipetting up and down with 1 μl of the 
corresponding crystallisation reagent. Working quickly to minimise evaporation, the 
cover slide was inverted over and sealed onto the corresponding reservoir. The 
crystallisation plates were incubated at 18 °C for at least 1 week, and the drops were 
examined under a light microscope. 
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For automated screening of crystallisation conditions, crystal trays were prepared by 
transferring 60 μl of each well solution from a commercial screen (Structure Screen 1 
or Structure Screen 2) to a 96-well microplate using a multi-channel pipette. The 
nanolitre liquid-handling robot was initialised and programmed according to the 
manufacturer‟s instructions. When the robot finished the pipetting programme, the 
crystallisation sheet was applied to the microplate, centering the drop(s) over the 
corresponding reservoir. The protective backing was removed from the cover sheet. 
The microplate was incubated at 18 °C for at least three days, and the drops were 
examined under a light microscope. 
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Chapter 3:   In silico analysis and production of yeast Isd11 
3.1 Bioinformatic studies suggest that Isd11 is a eukaryote-specific 
mitochondrial protein with a high α-helical propensity 
In an attempt to understand and predict structural and functional features of Isd11 as 
well as to develop new experimental strategies, several web-based bioinformatic 
tools were applied. The amino acid sequence of yeast Isd11 retrieved from the 
Saccharomyces Genome Database (SGD) was used in a Position-Specific Iterated 
BLAST (PSI-BLAST) search (Altschul et al., 2005) against NCBI‟s non-redundant 
protein sequence database to identify putative/established homologues. Different 
from BLASTP, PSI-BLAST greatly increases sensitivity to weak but biologically 
relevant sequence similarities. Homologues of yeast Isd11 were detected in fungi, 
plants, and animals, but no prokaryotic homologues were found, supporting the 
previous reports on the eukaryotic addition of Isd11 to the prokaryote-derived ISC-
assembly machinery (Adam et al., 2006; Wiedemann et al., 2006; Richards & van 
der Giezen, 2006). Selected homologous sequences were aligned and compared 
using ClustalW (Larkin et al., 2007). Primary structural conservation is not restricted 
to a particular segment of Isd11; it extends from N- to C-terminus (Figure 3.1). 
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Figure 3.1 Multiple alignment of deduced amino acid sequences of Isd11 proteins from 
taxonomically diverse organisms. Identical residues are indicated by an asterisk, and conservative and 
semi-conservative substitutions are indicated by a colon and a dot, respectively. (Os for Orzya sativa; 
Pt for Paramecium tetraurelia; Hs for Homo sapiens; Dm for Drosophila melanogaster; Sc for 
Saccharomyces cerevisiae) 
MitoProt II (Claros & Vincens, 1996), a dedicated software for calculating the N-
terminal protein region supporting a mitochondrial targeting sequence and the 
associated cleavage site, inferred that the first 10 amino acids form a basic 
amphipathic helix containing the mitochondrial targeting information. The inferred 
mature Isd11 protein itself was also predicted to be composed of three α-helices 
(Figure 3.2) by using Porter, a reliable server for protein secondary structure 
prediction (Pollastri & McLysaght, 2005). 
In addition to the amino acid sequence, the nucleotide sequence of yeast isd11 
retrieved from SGD was also analysed to determine the occurrence and distribution 
of rare E. coli codons. Rare codons are those codons that are rarely found in highly 
expressed genes of a given host and include AGG (which encodes Arg), AGA (Arg), 
AUA (Ile), CUA (Leu), CGA (Arg), CGG (Arg), and CCC (Pro) in E. coli (Kane, 
1995). The presence of rare codon clusters or a large number of single rare codons in 
the cloned isd11 gene could introduce translational problems in E. coli. A search of 
the nucleotide sequence for rare codons revealed that the inferred mature Isd11 
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protein contains 6 Arg and 1 Leu codons that E. coli does not normally encounter 
(Figure 3.2). 
 
Figure 3.2 Predictive analysis of the primary sequence of yeast Isd11 based on bioinformatic tools. 
10-residue block in red represents the putative mitochondrial targeting sequence, with the cleavage 
site indicated by a triangle. 3-residue block in green represents the LYR (LYK) motif. Residues in 
blue represent the amino acids encoded by rare E. coli codons. Black bars show the predicted 
consensus secondary structure of the protein. 
Given the fact that Isd11 is a novel protein with no structurally characterised 
homologues, ab initio protein modelling was applied to predict its 3D structure. The 
process involves developing libraries of short segments, which, in turn, are used for 
building bigger structures. The primary sequence of the predicted mature form of 
Isd11 was used to feed Robetta, a server that provides automated tools for protein 
structure prediction and analysis (Kim et al., 2004). The Robetta server generated 
five models that represent the centres of the five largest clusters of conformations 
(Figure 3.3). 
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Figure 3.3 Top-scoring (energy rank = 1) ab-initio model of yeast Isd11. The image was generated 
using PyMOL (http://www.pymol.org). 
Although protein fold recognition by threading proved to be inconclusive, the 
compact all-helical fold of Isd11 resembles a nucleic-acid-binding motif. 
3.2 The DNA fragment encoding the predicted mature form of 
Isd11 can be overexpressed in the E. coli system 
The DNA fragment encoding the predicted mature form of Isd11, Isd11Δ1–10, was 
amplified directly from the genomic DNA of yeast (Figure 3.4). To minimise the 
likelihood of mutations introduced by standard PCR, high-fidelity PCR using the 
proofreading PfuUltra DNA polymerase was used. Following double digestion with 
restriction enzymes, the PCR product was directionally cloned into the pET-14b 
vector with compatible DNA ends. The resulting construct, designated pKT1, was 
confirmed by DNA sequencing. 
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Figure 3.4 Agarose gel electrophoretic analysis of PCR-amplified isd11Δ1–30. The wide-range 
DNA ladder is shown on the left. The size of relevant reference DNA fragments and the amplicon are 
indicated next to each band. 
To enhance the expression of the Isd11Δ1–10-encoding insert, the rare-codon-
optimiser strain RosettaBlue(DE3)pLysS was selected as the expression host. 
Besides compensating for the rare codons encoding Arg and Leu, 
RosettaBlue(DE3)pLysS cells produce T7 lysozyme to repress low-level 
transcription from the T7 RNA polymerase promoter before IPTG induction, 
stabilising inserts encoding potentially toxic proteins. Analytical-scale expression 
screening revealed that yeast Isd11 could be expressed at high levels using the IPTG-
inducible pET-14b/RosettaBlue(DE3)pLysS protein production system (Figure 3.5). 
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Figure 3.5 SDS–polyacrylamide gel electrophoretic analysis of Isd11Δ1–10 overproduced on an 
analytical scale. N for non-induced total cell protein; I for induced total cell protein. 
3.3 Recombinantly produced Isd11 is deposited as inclusion bodies 
in the cytoplasm of host cells 
Preparative-scale expression experiments performed at various IPTG concentrations 
(0.4 mM, 0.2 mM or 0.1 mM) and induction temperatures (37 °C, 25 °C or 18 °C) 
for various incubation times (2 h, 4 h or 14 h) yielded no soluble Isd11 as revealed 
by the protein‟s absence in cleared lysates. Hence, it was concluded that recombinant 
Isd11 has an absolute tendency to form insoluble aggregates called inclusion bodies. 
Inclusion bodies arise by deposition of partially folded or misfolded proteins through 
the exposition of hydrophobic patches and the resultant non-covalent intermolecular 
attractions (Villaverde & Carrió, 2003). Knowing that Isd11 was deposited as 
inclusion bodies, the original purification protocol described for Nfs1 was modified 
so as to include urea as the denaturant. Immobilised Ni
2+
-affinity chromatography 
under denaturing conditions yielded a single band corresponding to the deduced 
molecular mass of His6-tagged Isd11Δ1–10 (12.4 kDa) as detected by SDS–PAGE 
(Figure 3.6). 
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Figure 3.6 SDS–polyacrylamide gel electrophoretic analysis of Isd11Δ1–10 produced on a 
preparative scale and purified by affinity chromatography under denaturing conditions. The pre-
stained protein ladder is shown on the left. The apparent molecular mass of relevant reference proteins 
and the deduced molecular mass of Isd11 are indicated next to each band. 
3.4 Denatured Isd11 cannot be readily refolded in vitro into its 
native state 
A considerable effort went into the recovery of Isd11 by refolding in vitro. Following 
inclusion body isolation, protein solubilisation with urea, and immobilised Ni
2+
-
affinity chromatography under denaturing conditions, Isd11Δ1–10 was subjected to 
refolding by: (i) immobilising the denatured protein onto a 5-ml HisTrap HP affinity 
column and gradually eliminating excess urea (also called on-column refolding), (ii) 
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diluting the denatured protein into a renaturation buffer supplemented with non-
detergent sulfobetaines, or (iii) diluting the denatured protein into a renaturation 
buffer containing the amphipathic carbohydrate-based polymer NV10 from 
Expedeon. Only the third approach was partially successful in recovering Isd11. The 
costly NV10 polymer, when used at the minimum recommended concentration, 
yielded very limited amounts of renatured Isd11 as revealed by the protein‟s 
presence in the cleared and concentrated renaturation buffer. 
3.5 Summary 
The novel fold of Isd11 made it difficult to infer precise molecular function solely on 
the basis of its primary structure, highlighting the necessity of experimental 
evidence. On the other hand, it was clear that Isd11 could not be easily prepared from 
E. coli cells in a soluble form in the quantities needed for biophysical 
characterisation. Perhaps Nfs1 could be used to solubilise Isd11 or the two proteins, 
Nfs1 and Isd11, could be co-expressed, allowing further characterisation of the role 
of Isd11. The production of Nfs1 and of the complex of Nfs1 and Isd11 are discussed 
in Chapter 4 and Chapter 5. 
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Chapter 4:   Production and characterisation of yeast Nfs1 
4.1 Bioinformatic studies of Nfs1 assist in the development of new 
experimental strategies 
In order to predict certain structural and functional aspects of Nfs1 as well as to drive 
new experiments, several publicly available in silico tools were employed. The 
amino acid sequence of yeast Nfs1 retrieved from the Saccharomyces Genome 
Database (SGD) was used in a Protein–Protein BLAST (BLASTP) search (Altschul 
et al., 2005) against NCBI‟s Protein Data Bank protein database to identify 
structurally characterised homologues. The top hit was E. coli IscS, which was 
followed by T. maritima NifS, rat and human selenocysteine lyases, and E. coli SufS 
respectively. Selected homologous sequences were aligned and compared (Figure 
4.1) using ClustalW (Larkin et al., 2007). 
 
Figure 4.1 Alignment of deduced amino acid sequences of E. coli (Ec) IscS and S. cerevisiae (Sc) 
Nfs1. Identical residues are indicated by an asterisk, and conservative and semi-conservative 
substitutions are indicated by a colon and a dot, respectively. The two proteins share 56% similarity. 
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MitoProt II (Claros & Vincens, 1996) predicted that the first 34 amino acid residues 
form a basic amphipathic helix containing the mitochondrial targeting information. A 
search of the nucleotide sequence for rare codons revealed that the predicted mature 
Nfs1 protein contains 20 Arg, 7 Leu, 4 Ile, and 3 Pro codons that E. coli does not 
normally encounter (Kane, 1995). Three of the Arg codons form a cluster that resides 
in the mid-region of the protein. 
4.2 Yeast Nfs1 constructs can be successfully overexpressed in E. 
coli 
The DNA fragments encoding the predicted mature form of Nfs1, Nfs1Δ1–34, and 
the truncated form of Nfs1, Nfs1Δ1–98, were amplified directly from the genomic 
DNA of yeast (Figure 4.2). To minimise the likelihood of mutations introduced by 
standard PCR, high-fidelity PCR using the proofreading PfuUltra DNA polymerase 
was used. Following double digestion with restriction enzymes, the PCR products 
were directionally cloned into the pET-14b vector with compatible DNA ends. pET-
14b encodes a cleavable N-terminal His6 tag that facilitates the affinity purification 
of Nfs1. The resulting constructs, designated pKT2 and pKT3, were validated by 
DNA sequencing. 
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Figure 4.2 Agarose gel electrophoretic analysis of PCR-amplified (A) nfs1Δ1–102 and (B) 
nfs1Δ1–294. The wide-range DNA ladder is shown on the left side of the PCR product of interest. The 
size of relevant reference DNA fragments and individual PCR products are indicated next to each 
band. 
A 
B 
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Analytical-scale expression screening showed that both Nfs1Δ1–34 and Nfs1Δ1–98 
can be expressed at high levels using the IPTG-inducible pET-14b/ 
RosettaBlue(DE3)pLysS protein production system (data not shown). 
4.3 Recombinantly produced Nfs1 is a soluble protein with a bright 
yellow colour attributable to PLP 
Overnight induction of preparative-scale E. coli cultures harbouring either pKT2 or 
pKT3 with 0.4 mM IPTG at 25 °C resulted in high levels of soluble Nfs1, indicating 
that a combination of the strong T7 RNA polymerase promoter and the rare-codon-
optimiser strain RosettaBlue(DE3)pLysS provides a very useful platform for soluble 
Nfs1 production. To purify Nfs1, the soluble cell fraction was first loaded onto a     
5-ml HisTrap HP affinity column. Nfs1 exhibited a bright yellow colour in 
accordance with the presence of protein-bound PLP. This characteristic colour 
allowed downstream purification and concentration steps to be easily tracked (Figure 
4.3). 
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Figure 4.3 Sample of Nfs1Δ1–34 captured on a HisTrap HP affinity column. The protein is bright 
yellow in colour, a characteristic attributable to bound PLP. 
Following immobilised Ni
2+
-affinity chromatography, the protein was loaded onto a 
120-ml HiPrep Sephacryl S-200 HR size-exclusion column for further purification at 
the preparative scale. The elution profiles of both Nfs1Δ1–34 and Nfs1Δ1–98 
showed a large symmetrical peak with a small leading shoulder (Figure 4.4). The 
peak fractions were collected and pooled accordingly. 
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Figure 4.4 Elution profiles of (A) and Nfs1Δ1–34 and (B) Nfs1Δ1–98 from the HiPrep Sephacryl 
S-200 HR size-exclusion column. The peaks containing the target protein are labelled. 
Protein homogeneity was verified by SDS–PAGE under reducing conditions, which 
yielded a single band corresponding to the calculated molecular mass of His6-tagged 
A 
B 
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Nfs1 (52.9 kDa for Nfs1Δ1–34; 46.5 kDa for Nfs1Δ1–98) (Figure 4.5). The protein, 
at 2 mg ml
-1
, could be stored at 4 °C for 8 weeks with no visible precipitation. 
 
A 
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Figure 4.5 SDS–polyacrylamide gel electrophoretic analysis of (A) Nfs1Δ1–34 and (B) Nfs1Δ1–
34, both produced on a preparative scale and purified by subsequent steps of affinity and size-
exclusion chromatographies. The pre-stained protein ladder is shown on the left side of the protein of 
interest. The apparent molecular mass of relevant reference proteins and the deduced molecular mass 
of Nfs1 isoforms are indicated next to each band. 
4.4 Size-exclusion chromatography indicates that recombinant Nfs1 
exists as a homodimer in solution 
In an attempt to estimate the apparent molecular mass of Nfs1 at the analytical scale, 
a 24-ml Superdex 200 10/300 GL size-exclusion column, which was previously 
calibrated with globular proteins of known molecular mass, was used. The apparent 
molecular mass of the Nfs1Δ1–34 was calculated from the calibration curve 
represented by the equation 
B 
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where Kav is the fraction of the stationary gel volume that is accessible to   Nfs1Δ1–
34 and Mr is the relative molecular mass of Nfs1Δ1–34 in kDa. Recombinant Nfs1 
has an apparent molecular mass of approximately 100 kDa, which corresponds to the 
mass of a homodimer. This finding is consistent with the previous studies on the 
characterisation of the oligomeric state of cysteine desulphurases (Zheng et al., 1993; 
Flint et al., 1996; Kaiser et al., 2000; Cupp-Vickery et al., 2003; Mühlenhoff et al., 
2004). 
4.5 UV-visible absorbance spectrophotometry confirms the 
presence of PLP and shows that recombinant Nfs1 is active 
towards L-cysteine 
UV-visible absorbance spectrophotometry, scanning wavelengths from 260 nm to 
500 nm, was used to characterise the bound chromophore. The spectrum was 
recorded at room temperature for purified Nfs1Δ1–34 (at a concentration of           
3.65 mg ml
-1
 in the SEC equilibration/elution buffer). Nfs1 displayed the typical UV-
visible absorbance spectrum of PLP-containing enzymes, giving two intense 
absorbance bands at 270 nm and 420 nm (Figure 4.6). The former is assigned to the 
aromatic residues tryptophan and tyrosine, and the latter is assigned to the protonated 
internal aldimine (Behshad & Bollinger, 2009). 
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Figure 4.6 UV-visible absorbance spectrum of Nfs1Δ1–34. The peaks at 270 nm and 420 nm 
correspond to the aromatic residues and the enzyme-bound PLP co-factor, respectively. 
The activity of recombinantly produced Nfs1Δ1–34 was assessed by incubating the 
protein with 10 mM free L-cysteine, with the reaction followed 
spectrophotometrically. The reaction was carried out at 4 °C in the SEC 
equilibration/elution buffer. DTT in the buffer reacts with the enzyme-bound 
persulphide, regenerating the active-site Cys residue and liberating sulphur in the S
2-
 
redox state (Fontecave & Ollagnier-de-Choudens, 2008). This is the reason why Nfs1 
was assayed in vitro in the absence of a specific sulphur-acceptor protein but in the 
presence of DTT, using L-cysteine as substrate. Measurements were taken at            
5-minute intervals over 20 minutes on a Hitachi U-3010 spectrophotometer 
maintained at room temperature. Because the substrate was used in high molar 
excess, the system displayed absorption bands corresponding to all long-living 
species (Figure 4.7). 
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Figure 4.7 Time-dependent spectral analysis of L-cysteine binding to Nfs1Δ1–34. Addition of free 
cysteine leads to a loss of absorption at 420 nm. At the same time, a second reaction intermediate 
absorbing at 330 nm is populated. 
Upon addition of L-cysteine, the intensity of the absorption band at 420 nm, assigned 
to the protonated internal aldimine, decreases with a concomitant increase of 
absorbance at 330 nm. The newly formed absorbing species represents the ketimine 
intermediate (Behshad & Bollinger, 2009). These results suggest that Nfs1 follows 
the same reaction scheme as its bacterial homologues (Figure 1.4). The change in 
absorbance at 420 nm (or 330 nm) is considerable for the first 5-minute interval, but 
then in subsequent 5-minute intervals the activity reduces. Clearly, the Nfs1–PLP 
adduct is not being regenerated, or else the peak at 420 nm would persist, so it is  
plausible that only a single turnover is being monitored. It may be that the high 
concentration of the free cysteine added (10 mM) competes with the catalytic 
cysteine, the sulphur acceptor, leading to a trapped substrate–PLP ketimine adduct. 
Alternatively, the 10 mM L-cysteine could form a disulphide with the cysteine on the 
flexible loop of Nfs1 preventing it from accepting the sulphur, again trapping the 
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ketimine. In either case it is clear that the enzyme-bound PLP is reacting with the 
free cysteine and forming the ketimine, revealing that the active centre of the 
recombinant enzyme is correctly formed. Nfs1 precipitated after overnight 
incubation with cysteine at 4 °C. This may be because the resting enzyme (Nfs1–SH) 
is more soluble than the persulphide compound (Nfs1–S–SH). 
4.6 Far-UV CD spectroscopy reveals that recombinant Nfs1 has an 
extensive α-helical content 
In an attempt to obtain reliable estimates of regular secondary structural features    
(α-helices, β-sheets, and turns) present in Nfs1, CD spectroscopy was applied in the 
region of peptide bond absorption (far-UV, from 185 nm to 260 nm). Nfs1Δ1–34 (at 
a concentration of 0.025 mg ml
-1
 in 10 mM potassium phosphate, pH 7.5, 
supplemented with 1 mM PLP) was used for the CD measurements. The far-UV CD 
spectrum (Figure 4.8), which represents a baseline-corrected cumulative average of 
three repeat scans, was measured at 25 °C on a Chirascan spectropolarimeter 
(Applied Photophysics), using a cell pathlength of 1 mm and a bandwith setting of     
1 nm. Data were normalised by scaling to molar concentrations of the repeating unit 
of the protein. For the far-UV CD spectroscopy, the repeating unit is the peptide 
bond, and each residue in the protein is associated with a peptide bond. Therefore, 
data are expressed in terms of the mean residue weight (115 Da for most proteins). 
The mean residue ellipticity ([θ]mrw) of Nfs1 at a given wavelength was calculated 
from the equation 
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where c is the Nfs1 concentration in mg ml
-1
, l is the cell pathlength in mm, mrw is 
the mean residue weight in Da, and θ is the ellipticity in millidegrees (mdeg). [θ]mrw 
has the units deg cm
2
 dmol
-1
. 
 
Figure 4.8 Far-UV CD spectrum of Nfs1Δ1–34. The bands at 208 and 222 nm are characteristic of 
a high content of α-helix. 
The spectrum of Nfs1 displayed two strong negative bands at 208 nm and 222 nm, 
coupled with a strong positive band at 190 nm. These signals indicate that the 
recombinantly produced protein is extensively α-helical. For a more detailed analysis 
of the far-UV CD data, the spectrum was deconvoluted via DichroWeb, a dedicated 
online server hosted by Birkbeck College, University of London (Whitmore & 
Wallace, 2004). DichroWeb makes use of a range of algorithms and reference 
databases to estimate the percentages of regular secondary structural elements. Use 
of the CDSSTR algorithm and the SP175 reference set (Lees et al., 2006) yielded the 
smallest (0.006) normalised root mean square deviation (NRMSD) value for the 
spectrum of Nfs1. NRMSD reflects the goodness-of-fit parameter and values of 
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equal to or less than 0.05 are considered to be ideal. NRMSD analysis, thus, suggests 
a nearly perfect fit between the calculated CD spectrum (which is derived from the 
reference proteins) and the spectrum of Nfs1 over the entire wavelength range used 
(190–240 nm for the SP175 reference set). Regular secondary structural elements 
were quantified accordingly, confirming the high helical propensity of the amide 
backbone (Table 4.1). 
Table 4.1 Calculated fractions of the regular secondary structural features of Nfs1Δ1–34. 
Predictions confirm the high α-helical propensity of Nfs1 and provide an insight into its β-sheet 
content. 
α-Helix β-Strand Turn Unstructured 
54.5% 7.9% 10.9% 26.7% 
 
Far-UV CD spectroscopy results are in agreement with those obtained from the X-
ray crystallographic studies of E. coli IscS, which contains a greater percentage of 
residues in α-helical conformation (40.1%) than β-stranded conformation (13.8%) 
(Cupp-Vickery et al., 2003). Although far-UV CD spectroscopy proved to be a very 
useful technique in describing the overall secondary structural elements of Nfs1, only 
X-ray crystallography could locate where these elements exist within the protein. 
4.7 Homology modelling provides insights into the structural 
organisation of Nfs1 and the integrity of its active site 
A considerable effort went into the crystallisation of Nfs1, using both Nfs1Δ1–34 
and Nfs1Δ1–98 (see Section 2.13 for details), but these crystallisation trials were 
unsuccessful. 50–70% of the drops contained precipitates, while the rest were clear at 
various protein concentrations tested (5–20 mg ml-1) (data not shown). Therefore, 
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homology or comparative modelling was employed to obtain a useful 3D model for 
the protein. The program MODELLER, which implements homology modelling 
through satisfaction of spatial restraints (Sali & Blundell, 1993; Fiser et al., 2000), 
was used to make a plausible model of the protein. Among all available molecular 
structures representing NifS-like proteins, E. coli IscS (PDB entry 1P3W) was 
identified as the best structural template for modelling yeast Nfs1Δ1–98. E. coli IscS 
shares 56% sequence identity with the Nfs1 target. The Nfs1 sequence was aligned 
with the IscS sequence using ClustalW (Larkin et al., 2007), and this alignment was 
used to feed MODELLER along with the atomic coordinates of IscS. The resulting 
model was inspected visually . 
Both IscS and Nfs1Δ1–98 have virtually the same overall topology with nearly 
identical secondary structural elements (Figure 4.9). 
 
Figure 4.9 Modelled overall structure of Nfs1Δ1–98. The two subunits are colour-coded cyan or 
yellow. α-helices are shown as cylinders. The image was generated using PyMOL 
(http://www.pymol.org). 
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The PLP cofactor is anchored in the active site of Nfs1 via formation of an internal 
aldimine Schiff base with Lys299 as well as a number of hydrogen bonds (Figure 
4.10). Asp239 and Gln242 help stabilise the position of the pyridine ring of PLP, 
while Thr135, Ser262 and His264 help stabilise the position of its phosphate group in 
the active site. 
 
Figure 4.10 Cartoon representation of the active site of Nfs1Δ1–98, with PLP and the PLP-binding 
residues shown in stick representation. The PLP co-factor is shown in magenta making a covalent link 
to Lys299. Polar interactions stabilising the position of PLP in the active site are indicated by yellow 
dashed lines. The image was rendered using PyMOL (http://www.pymol.org). 
The catalytic cysteinyl residue (Cys328) of IscS is located in the middle of a 10-
residue-long flexible loop (GSACTSASLE), which is directed away from the active 
site (Cupp-Vickery et al., 2003). This residue corresponds to Cys421 in Nfs1 and is 
proposed to act as a nucleophile to attack the sulfhydryl group of the PLP-bound L-
cysteine substrate, forming a protein-bound cysteinyl persulfide intermediate (Zheng 
et al., 1994).  As Cys328 is missing from the crystal structure of IscS, no attempt was 
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made to model this flexible loop, though it is clearly within reach of the active 
centre. 
4.8 Summary 
Yeast Nsf1 was successfully overproduced in E. coli, making pKT2 and pKT3 
among the first constructs shown to yield soluble Nfs1 upon expression under the T7 
RNA polymerase promoter in a prokaryotic host. Both the sequence identity and 
biophysical data support the view that Nfs1 has the same architecture as bacterial 
IscS and, like the bacterial enzyme, is a homodimer in solution. There is clear 
evidence of PLP binding to Nfs1 and its active centre closely resembles that of IscS, 
suggesting conservation of the catalytic mechanism. 
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Chapter 5:   Production of the yeast Nfs1/Isd11 protein 
complex and studies of the Nfs1–Isd11 interaction 
5.1 Co-expression of the two target DNA fragments in E. coli allows 
formation of the Nfs1/Isd11 protein complex 
The DNA fragments encoding the predicted mature forms of Isd11 and Nfs1, 
Isd11Δ1–10 and Nfs1Δ1–34 respectively, were amplified directly from the genomic 
DNA of yeast. PCR primers were engineered so as to introduce a non-cleavable His6 
tag to the N-terminus of Nfs1 upon translation. To minimise the likelihood of 
mutations introduced by standard PCR, high-fidelity PCR using the proofreading 
PfuUltra DNA polymerase was used. Following double digestion with the 
appropriate restriction enzymes, the PCR products were sequentially inserted into the 
two separate multiple cloning sites of the same pCDFDuet-1 vector, which 
introduced a second non-cleavable His6 tag to the N-terminus of Isd11 upon 
translation, using a ligation-dependent cloning strategy to generate the co-expression 
construct designated pKT4. The integrity of pKT4 was confirmed by DNA 
sequencing. 
Unlike pET-14b carrying a plain T7 promoter, pCDFDuet-1 carries two T7lac 
promoters (which involve T7 RNA polymerase promoters followed by lac operators) 
that provide tighter regulation over basal expression. Since the use of a plasmid 
carrying a T7lac promoter in combination with a host strain bearing a pLysS plasmid 
is not recommended by the manufacturer, the former RosettaBlue(DE)pLysS strain 
was replaced with the similar RosettaBlue(DE3) strain. Overnight induction of 
preparative-scale bacterial cultures bearing pKT4 with 1 mM IPTG at 25 °C resulted 
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in high levels of soluble Nfs1/Isd11, suggesting that a combination of the dual T7lac 
promoters and the rare-codon-optimiser strain RosettaBlue(DE3) provides a very 
useful platform for the co-expression of the DNA fragments encoding Nfs1 and 
Isd11. 
To purify Nfs1/Isd11, the soluble cell fraction was first loaded onto a 5-ml HisTrap 
HP affinity column. Following immobilised Ni
2+
-affinity chromatography, the 
protein was loaded onto a 120-ml HiPrep Sephacryl S-200 HR size-exclusion column 
for further purification at the preparative scale. The elution profile of Nfs1/Isd11 
showed a large symmetrical peak with a small trailing shoulder (Figure 5.1). The 
peak fractions containing the Nfs1/Isd11 complex were collected and pooled 
accordingly. 
 
Figure 5.1 Elution profile of the Nfs1/Isd11 complex from the HiPrep Sephacryl S-200 size-
exclusion column. The peak containing the complex is labelled. 
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Protein homogeneity was confirmed by reducing SDS–PAGE, which yielded two 
bands corresponding to the computed molecular mass of His6-tagged Nfs1Δ1–34 
(51.5 kDa) and His6-tagged Isd11Δ1–10 (11.8 kDa) (Figure 5.2). The protein, at        
2 mg ml
-1
, could be stored at 4 °C for more than 8 weeks with no visible 
precipitation. 
 
Figure 5.2 SDS-PAGE analysis of the purified and concentrated Nfs1/Isd11 complex, showing the 
dissociated subunits Nfs1 and Isd11. The pre-stained protein ladder is shown on the left. 
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5.2 Size-exclusion chromatography estimates that the Nfs1/Isd11 
complex has a native mass nearly twice that of the Nfs1 
homodimer 
In an attempt to estimate the apparent molecular mass of Nfs1/Isd11 at the analytical 
scale, a 24-ml Superdex 200 10/300 GL size-exclusion column, which was 
previously calibrated with globular proteins of known molecular mass, was used. The 
molecular mass of the Nfs1/Isd11 complex was calculated from the calibration curve 
represented by the equation 
                         
where Kav is the fraction of the stationary gel volume that is accessible to Nfs1/Isd11 
and Mr is the relative molecular mass of Nfs1/Isd11 in kDa. Recombinantly produced 
Nfs1/Isd11 has an apparent molecular mass of approximately 190 kDa, suggesting 
that Nfs1 adopts a higher oligomeric state upon complexation. 
5.3 UV-visible absorbance spectrophotometry reveals that 
recombinantly produced Nfs1/Isd11 retains its activity towards 
L-cysteine and that Isd11 helps stabilise Nfs1 during and/or 
after the catalytic desulphuration of L-cysteine 
The UV-visible absorbance spectrum of the complex was recorded at room 
temperature for purified Nfs1Δ1–34/Isd11Δ1–10 (at 3.65 mg ml-1 in the SEC 
equilibration/elution buffer). Nfs1/Isd11 showed almost the same spectral profile as 
Nfs1, giving two intense absorbance bands at 280 nm and 420 nm (Figure 5.3). The 
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former is attributed to the aromatic residues tryptophan and tyrosine, and the latter is 
attributed to the protonated internal aldimine (Behshad & Bollinger, 2009). 
 
Figure 5.3 UV-visible absorbance spectrum of Nfs1/Isd11. The peaks at 280 nm and 420 nm 
correspond to the aromatic residues and the enzyme-bound PLP co-factor, respectively. 
The activity of recombinant Nfs1/Isd11 was assayed by incubating the protein 
complex with 10 mM free L-cysteine, with the reaction monitored 
spectrophotometrically. The reaction was conducted at 4 °C in the SEC 
equilibration/elution buffer. Measurements were taken at 5-minute intervals over    
20 minutes on a Hitachi U-3010 spectrophotometer maintained at room temperature. 
Because the substrate was used in high molar excess, the system displayed 
absorption bands corresponding to all long-living species (Figure 5.4). 
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Figure 5.4 Time-dependent spectral analysis of L-cysteine binding to Nfs1/Isd11. Addition of free 
cysteine leads to a loss of absorption at 420 nm. Simultaneously, a second reaction intermediate 
absorbing at 336 nm is populated. 
With L-cysteine added, the intensity of the absorption band at 420 nm, attributed to 
the protonated internal aldimine, decreases with a concomitant increase of 
absorbance at 336 nm. The newly formed absorbing species represents the ketimine 
adduct of PLP and the L-cysteine substrate (Behshad & Bollinger, 2009). These 
results indicate that the active centre of recombinantly produced Nfs1/Isd11 is 
correctly formed and that the complex follows the same reaction scheme as Nfs1 and 
its bacterial homologues, raising the question of what the specific function of bound 
Isd11 is. One explanation is that Isd11 may act as an adaptor protein, linking 
multiple copies of the Nfs1 monomer. This would increase the effective 
concentration of the desulphurase enzyme. Alternatively, Isd11 may facilitate the 
onward transfer of elemental sulphur released from L-cysteine. 
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As in the case of Nfs1, only a single turnover is observed here. The change in 
absorbance at 420 nm (or 336 nm) is considerable for the first 5-minute interval, but 
then in subsequent 5-minute intervals the activity reduces. However, the spectral 
pattern of Nfs1/Isd11 is different from that of Nfs1 in such a way that the spectra 
corresponding to the 15
th
 and the 20
th
 minutes can still be distinguished from each 
other, suggesting that the complex maintains its activity for a longer period of time 
compared to Nfs1. Unlike Nfs1, Nfs1/Isd11 showed no signs of precipitation 
following overnight incubation with cysteine at 4 °C. Isd11, therefore, seems to 
stabilise Nfs1 during and/or after the L-cysteine desulphuration reaction. 
5.4 Quantitative amino acid analysis of Nfs1/Isd11 suggests that 
Nfs1 interacts with Isd11 in a 1:1 ratio 
A considerable effort was devoted to determining the relative ratio of subunits in the 
Nfs1/Isd11 protein complex. Quantitative Western blot analysis of purified 
Nfs1/Isd11, using the Odyssey Infrared Imaging System, was adopted as the first 
choice for quantifying His6-tagged subunits (see Section 2.7 for details). This 
method, however, failed to provide useful information due to impaired transfer of 
Isd11 onto the PVDF membrane. In this second approach, a sample of Nfs1/Isd11 in 
4 mM HEPES, pH 7.0, 40 mM NaCl, 0.2 mM DTT, 0.2 mM EDTA, and 1% (v/v) 
glycerol was sent to the Protein and Nucleic Acid Chemistry Facility at the 
University of Cambridge for quantitative amino acid analysis. Standard analysis of 
protein hydrolysates was performed by ion-exchange chromatographic separation of 
individual amino acids, monitored by ninhydrin reaction. One run identified all 
hydrolysate amino acids except tryptophan and cysteine. Asparagine and glutamine 
114 
 
were hydrolysed to aspartate and glutamate, respectively, during the protocol.  (Table 
5.1). 
Table 5.1 Quantitative amino acid analysis of Nfs1/Isd11. The amino acid compositions (number 
of each residue per monomer) of Nfs1 and Isd11 are given in the top two columns. The added 
contribution of hydrolysed Asn residues to the total number of Asp residues is indicated by Asx. 
 Nfs1 Isd11 
Ala 46 2 
Arg 24 6 
Asn 19 9 
Asp 26 4 
Cys 5 0 
Gln 10 8 
Glu 29 4 
Gly 35 3 
His 22 7 
Ile 28 2 
Leu 39 9 
Lys 28 9 
Met 13 4 
Phe 14 7 
Pro 20 3 
Ser 36 7 
Thr 29 4 
Trp 3 0 
Tyr 14 4 
Val 30 6 
 
 Nfs12–Isd11 Nfs1–Isd11 Nfs1–Isd112 
 Expected Found Variance Expected Found Variance Expected Found Variance 
Ala 94 99.64 0.34 48 54.57 0.90 50 64.06 3.95 
Arg 54 52.33 0.05 30 28.66 0.06 36 33.64 0.15 
Asx 103 100.21 0.08 58 54.88 0.17 71 64.43 0.61 
Gly 73 73.26 0.00 38 40.12 0.12 41 47.1 0.91 
His 51 38.12 3.25 29 20.88 2.27 36 24.51 3.67 
Ile 58 56.72 0.03 30 31.06 0.04 32 36.46 0.62 
Leu 87 96.77 1.10 48 53 0.52 57 62.22 0.48 
Lys 65 60.51 0.31 37 33.14 0.40 46 38.9 1.10 
Phe 35 32.61 0.16 21 17.86 0.47 28 20.97 1.77 
Pro 43 40.89 0.10 23 22.39 0.02 26 26.29 0.00 
Thr 62 62.57 0.01 33 34.27 0.05 37 40.23 0.28 
Tyr 32 25.51 1.32 18 13.97 0.90 22 16.4 1.43 
Val 66 72.83 0.71 36 39.88 0.42 42 46.82 0.55 
   Avg. 0.57   Avg. 0.49   Avg. 1.19 
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From comparison of the average variance contributions of reliable amino acids for 
each of the three possible repeating units (Nfs12–Isd11, Nfs1–Isd11 and Nfs1–
Isd112), Nfs1 is most likely to interact with Isd11 in a molar ratio of 1:1. 
5.5 Analytical ultracentrifugation suggests that Nfs1 and Isd11 
associate to form the (Nfs1/Isd11)3 heterohexamer 
To precisely characterise the oligomeric architecture of the Nfs1/Isd11 protein 
complex, analytical ultracentrifugation (AUC) was performed by my colleague, Dr 
Rebecca Beavil, from King‟s College London. The sedimentation-equilibrium AUC 
experiment was set up with three different concentrations (A280 = 0.8, A280 = 0.6 and 
A280 = 0.4) of the Nfs1/Isd11 complex loaded in three different analytical cells of an 
Optima XL-A analytical ultracentrifuge (Beckman Coulter) at the same time. The 
samples were run at three different rotor speeds (7,000 rpm, 8,500 rpm and      
10,000 rpm) at 4 °C. The AUC data from three different protein concentrations at a 
given speed were fitted simultaneously to a range of models. The best fit was 
obtained for a non-interacting two-species model which makes use of a modified 
version of the equation given in Section 2.6. This model suggested that the sample 
was a mixture of mostly the (Nfs1/Isd11)3 heterohexamer with some non-interacting 
material of fixed molecular mass (approximately one-third the size of the 
(Nfs1/Isd11)3 heterohexamer), which could be a degradation product, a broken 
complex or a contaminating protein (Figure 5.5). 
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Figure 5.5 Sedimentation equilibrium profile at 280 nm, and the corresponding residuals, for the 
Nfs1/Isd11 complex run at 8,500 rpm. The model comprising (Nfs1/Isd11)3 and a smaller non-
interacting component describes the experimental data best. Loading concentrations are shown in 
different symbols, as: A280 of 0.8 is indicated by circles; A280 of 0.6 is indicated by squares; A280 of 0.4 
is indicated by triangles. 
The accuracy of each fit was judged by the residuals and statistics. Unlike the 
(Nfs1/Isd11)3 heterohexamer model, which produced a random distribution of 
residuals around zero, the (Nfs1/Isd11)2 heterotetramer and the (Nfs1/Isd11)4 
heterooctamer models yielded poor fits of the curves to the sedimentation 
equilibrium data (Figure 5.6). 
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Figure 5.6 Sedimentation equilibrium profile at 280 nm, and the corresponding residuals, for the 
Nfs1/Isd11 complex run at 8,500 rpm. Poor fits of the curves to the experimental data are obtained 
with (A) (Nfs1/Isd11)2 and (B) (Nfs1/Isd11)4 models. These poor-fits are accompanied by the 
unevenly distributed residuals. Loading concentrations are shown in different symbols, as: A280 of 0.8 
is indicated by circles; A280 of 0.6 is indicated by squares; A280 of 0.4 is indicated by triangles. 
 
 
A 
B 
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5.6 Intrinsic tryptophan fluorescence measurements indicate a 
conformational change in Nfs1 upon Isd11 binding 
In contrast to Isd11, which lacks tryptophans, Nfs1 contains three tryptophanyl 
residues at positions 138, 480 and 494. In an attempt to obtain information regarding 
the accessibility and microenvironment of these intrinsic fluorophores, the emission 
spectra of Nfs1Δ1–34  both alone and in complex with Isd11Δ1–10 were recorded 
(Figure 5.7). Protein (at 0.12 mg ml
-1
 in the SEC elution buffer) was used for the 
fluorescence measurements, which were performed on a Hitachi F-2500 fluorescence 
spectrophotometer maintained at room temperature. The excitation wavelength was 
set at 295 nm to minimise interference from tyrosinyl residues, and the emission 
scans were acquired from 315 nm to 400 nm, using excitation and emission slit 
widths of 10 nm. Data were reported without subtracting the buffer signal as it did 
not contribute significantly to the fluorescence intensity of the proteins. 
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Figure 5.7 Comparison of the emission spectra of Nfs1 and the Nfs1/Isd11 complex. Upon 
complex formation, the intensity of Nfs1 fluorescence quenches and the emission band shifts to a 
lower wavelength. 
From inspection of the emission spectra of Nfs1 and Nfs1/Isd11, it is clear that Nfs1 
adopts a conformation different to that in free form when it is in complex with Isd11. 
Upon Isd11 binding, the emission maximum for Nfs1 shifts from 348 nm to 343 nm, 
suggesting that one or more tryptophans become less exposed to the aqueous buffer. 
With Isd11 bound, intrinsic tryptophan fluorescence also quenches by 21%, which is 
possibly due to the varying interaction of tryptophans with peptide bonds and a 
number of amino acid side-chains within the complex structure. There are two 
plausible explanations for these findings: (i) the buried tryptophan is normally 
situated in the Nfs1–Isd11 binding site; (ii) the binding of Isd11 induces a 
conformational change in Nfs1 in such a way that the tryptophan becomes more 
buried. On the basis of the limited data available from this experiment, it is difficult 
to assign tryptophans. 
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5.7 Far-UV CD spectroscopy supports the earlier indication that 
Nfs1 undergoes a conformational rearrangement upon complex 
formation 
In addition to fluorescence spectrophotometry, CD spectroscopy can also be 
employed to characterise protein–protein interactions in structural terms. 
Measurement of an alteration in the far-UV CD spectroscopic signal of Nfs1 upon 
complex formation made it possible to structurally investigate the interaction 
between Nfs1 and Isd11. CD spectra of Nfs1Δ1–34 and Nfs1Δ1–34/Isd11Δ1–10 in 
the region 200–260 nm (Figure 5.8), both representing a baseline-corrected 
cumulative average of three repeat scans, were obtained at 25 °C on a Chirascan 
spectropolarimeter (Applied Photophysics), using a cell pathlength of 1 mm and a 
bandwith setting of 1 nm. Both proteins were used at a concentration of 0.12 mg ml
-1
 
in 2.5 mM HEPES, pH 7.0, supplemented with 25 mM NaCl. Data were normalised 
by calculating the mean residue ellipticity, [θ]mrw. This allowed spectra in the far-UV 
region to be directly compared for Nfs1 and the Nfs1/Isd11 complex. 
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Figure 5.8 Comparison of the far-UV CD spectra of Nfs1 and Nfs1/Isd11. Binding of Isd11 leads 
to a considerable loss of the CD signal at 208 nm, with a moderate loss at 222 nm. 
The binding of Isd11 was monitored by changes in the ellipticity at 208 nm and    
222 nm. It is evident that there is a relatively greater change in the former signal 
(69% compared to 29%). Although secondary-structure prediction tools point to the 
predominantly α-helical nature of Isd11, far-UV CD spectroscopy suggests a 
decrease in the helical content of Nfs1 in complex with Isd11. This phenomenon can 
be explained by the fact that complex formation sometimes results in a considerable 
alteration in the spectroscopic signal even when the estimated contents of secondary 
structural elements remain essentially the same (Kelly & Price, 2006). Therefore, 
changes in the far-UV CD spectrum of the Nfs1/Isd11 protein complex may show 
alterations in the orientation of helices with respect to each other rather than the 
actual content of helices, supporting the intrinsic tryptophan fluorescence studies. 
Although the possibility exists that Isd11 may adopt a conformation other than the  
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α-helical type (i.e., β-sheet or random coil), its contribution to the signal must be 
small compared with that of Nfs1, which is roughly five times the size of Isd11. 
5.8 Summary 
The experimental evidence clearly shows that the Nfs1/Isd11 complex is more 
massive than the Nfs1 homodimer, suggesting that Isd11 adds on to the Nfs1 
homodimer or brings homodimers together. Quantitative amino acid analysis 
supports a 1:1 ratio of Nfs1 to Isd11, placing an important constraint on the 
composition of the complex, which must comprise an equal number of Isd11 and 
Nfs1 subunits. Size-exclusion chromatography and the more precise 
ultracentrifugation measurements both suggest that the complex comprises Nfs13–
Isd113, giving a mass of approximately 190 kDa. This is quite surprising due to the 
fact that Nfs1 alone is a homodimer. If Isd11 promoted oligomerisation of the Nfs1 
homodimer, then the simplest oligomeric state would be a dimer of dimers, with 
composition Nfs14–Isd114. This would have a mass of approximately 250 kDa. It is 
the analytical ultracentrifugation result that cannot be ignored; the size-exclusion 
column is imprecise and errors could account for the discrepancy in measured size. 
However, one is left with the analytical ultracentrifugation result, which indicates 
that a considerable rearrangement of Nfs1 subunits occurs in the complex. Clearly, 
such an unexpected result requires more corroborating evidence to confirm. 
One source of such corroborating evidence comes from the far-UV CD 
measurements, which show changes in the structure of Nfs1 in the complex 
compared with Nfs1 alone. However, one should be cautious about such indirect 
measurements. What is needed is the application of a battery of other techniques to 
support or refute the existence of the (Nfs1/Isd11)3 heterohexamer. Such studies 
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would include small-angle X-ray and neutron scattering as well as the ultimate 
arbitrator in many instances, direct visualisation of the complex in the crystal lattice 
revealing its oligomeric state. During the course of this project, no crystals of the 
Nfs1/Isd11 protein complex could be grown. For all the protein concentrations tested               
(5–20 mg ml-1), about 30–50% clear and 50–70% precipitate-containing drops were 
observed in manual and automated crystal screens (data not shown).  
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Chapter 6:   Conclusion and future prospects 
The primary ISC assembly machinery of eukaryotes, which is responsible for the 
maturation of mitochondrial Fe–S proteins, is found in mitochondria or in 
mitochondrial remnants called mitosomes and hydrogenosomes in some parasites. 
This conservation of the ISC assembly machinery in mitosomes and 
hydrogenosomes obviously reflects the critical contribution of these organelles to 
parasite physiology. The maturation of cytosolic and nuclear Fe–S proteins requires 
several more extramitochondrial components that belong to the CIA machinery.    
Fe–S proteins are quite evidently among the key players for virtually all organisms in 
cellular events. The essential pathway of Fe–S cluster formation, therefore, presents 
an opportunity for researchers to develop novel antiparasitic drugs, in particular 
when the Fe–S cluster assembly proteins are significantly divergent from their 
mammalian counterparts. 
Although a large subset of the Fe–S cluster assembly proteins have now been 
characterised, there is little understanding of how different proteins of this 
biosynthetic pathway interact together (either stably or transiently) in a complex 
functional network to assemble Fe–S clusters from scratch. Biochemical, biophysical 
and structural studies of the multiprotein complexes involved in Fe–S cluster 
assembly and delivery to recipient apoproteins will provide insight into the in vivo 
mechanism for Fe–S protein maturation and allow for the replication of the process 
in vitro. Such knowledge represents an important prerequisite to developing future 
diagnostic and therapeutic approaches for the prevention and treatment of human 
diseases linked to Fe–S cluster assembly. 
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Yeast Isd11, which is a recently identified component of the ISC assembly apparatus, 
is a small (11 kDa) protein carrying an overall basic charge (theoretical pI 10.3). It is 
assigned to the LYR family (Pfam entry PF05347), which is characterised by the 
presence of a conserved LYR (or LYK) tripeptide motif near the N-termini of its 
protein members. Other LYR-motif-containing proteins include the 14-kDa and     
22-kDa subunits, B14 and B22 respectively, of mitochondrial complex I (which is 
absent in S. cerevisiae) and the 13-kDa assembly factor, SDHAF1, of mitochondrial 
complex II. Given that both complex I and complex II contain multiple Fe–S 
clusters, all these data raise the question of whether the LYR motif is a signature of 
relatively small, mitochondrial proteins involved in the formation, insertion and/or 
retention of Fe–S clusters (Ghezzi et al., 2009). In this Thesis, I show that co-
expression of isd11 and nfs1 in E. coli aids in recovering Isd11 from inclusion 
bodies, in the form of a soluble two-protein complex (Nfs1/Isd11). However, it was 
not possible to produce soluble Isd11 in isolation in reasonable quantities, which 
presented a major challenge to this project. Eukaryotic expression systems (e.g., 
Saccharomyces and Pichia), cell-free translation systems (e.g., wheat germ) or 
chemical synthesis might hold promise in this regard. Had it been possible to 
produce Isd11 in the absence of Nfs1, then the conformation could have been probed 
by NMR spectroscopy using isotropically enriched (
15
N and 
13
C) protein. Changes in 
conformation on complexation with Nfs1 could also have been monitored by 
following changes in the chemical shifts. Titration of Isd11 into Nfs1 could also have 
been followed thermodynamically (e.g., by isothermal titration calorimetry) as well 
as spectroscopically (e.g., by NMR and fluorescence spectrophotometry) allowing 
the stoichiometry of this complex and affinity of its constituting proteins towards 
each other to be determined precisely. 
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Interestingly, E. coli possesses a small (8 kDa) protein called IscX, which forms a 
tight complex with IscS (Tokumoto et al., 2002). IscX carries an overall acidic 
charge (theoretical pI 4.0) and is encoded by the last gene in the isc operon. The 
NMR structure of IscX has revealed that the protein exists as a monomer in solution 
and adopts a compact three-helix fold bearing close resemblance to that of DNA-
binding proteins (Pastore et al., 2006). IscX has no primary sequence similarity to 
Isd11, though both proteins appear to have a compact all-helical fold which may be a 
key aspect of their recognition by cysteine desulphurases. If eukaryotes lost IscX 
from the mitochondrial endosymbiont but maintained IscS (Nfs1), then they had to 
invent a novel functional analogue, which could be Isd11. A useful experiment 
would be to investigate if there is an interaction between IscX and Nfs1 by 
complementing a yeast Isd11 knock-out strain with E. coli IscX. Although IscX is 
proposed to be an adaptor of IscS, genetic studies have shown that IscX is not 
essential for Fe–S cluster assembly (Tokumoto & Takahashi, 2001). 
Unlike Isd11, Nfs1 is a well-known component of the mitochondrial ISC assembly 
machinery. It is a PLP-dependent enzyme that catalyses the conversion of L-cysteine 
to L-alanine and elemental sulphur. The latter product is bound to a conserved 
cysteinyl residue, in the form of a persulphide intermediate, and, subsequently, 
transferred to a recipient protein. Here, I report the production of the predicted 
mature form of yeast Nfs1 (Nfs1Δ1–34) and a further truncated version of the same 
protein (Nfs1Δ1–98) for the first time in E. coli. I propose that Nfs1Δ1–98 is more 
suitable than Nfs1Δ1–34 for crystallisation experiments because it corresponds to the 
crystallisable fold of E. coli IscS. UV–visible absorbance spectophotometry proved 
to be an excellent tool for following the cysteine desulphuration reaction as the 
reaction intermediates have distinct absorbance characteristics in the region         
127 
 
330–510 nm. Stopped-flow UV–visible absorbance spectrophotometry could be used 
to identify all of the accumulating intermediates, tentatively map them onto the 
proposed mechanism (Figure 1.4) and determine the kinetic parameters of each step. 
Selenocysteine lyases, which are also PLP-dependent enzymes, catalyse the 
degradation of L-selenocysteine to yield L-alanine and selenium. Although 
selenocysteine lyases share several common features with cysteine desulphurases 
(such as the PLP-binding lysine, active-site cysteine and acid/base catalyst histidine), 
there is only a limited degree of sequence identity between the two groups of 
enzymes. Recently, selenocysteine lyase (SCL) from T. brucei has been characterised 
(Poliak et al., 2009). When compared with Nfs1 from the same organism, SCL lacks 
the C-terminal region consisting of a short α-helix and a trailing flexible segment, as 
revealed by the crystal structure of IscS (Figure 6.1). What is more, although Nfs1 
co-purifies with its functional partner Isd11, SCL seems not to interact stably with 
any other protein. Taken together, these findings imply that Isd11 is likely to bind to 
the C-terminus of Nfs1, stabilising the flexible flanking residues in an appropriate 
conformation. Two of the three tryptophanyl residues of yeast Nfs1 reside in this C-
terminal region, which is absent in T. brucei SCL, possibly explaining the occurrence 
of a blue-shift of the emission maximum upon Isd11 binding (see Section 5.6). This 
hypothesis could be tested by mutating one or more of the conserved amino acids 
residing in the C-terminus of Nfs1 and, subsequently, observing the effect of this on 
the Nfs1–Isd11 interaction. 
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Figure 6.1 Alignment of deduced amino acid sequences of selenocysteine lyase (SCL) and the 
predicted mature form (Smíd et al., 2006) of cysteine desulphurase (Nfs1) both from T. brucei. The C-
terminal region of Nfs1, which is  absent in SCL, may be critical in Isd11 binding. The 6-residue-long 
α-helix is underlined in red, and the 12-residue-long mobile segment is underlined in green. Identical 
residues are indicated by an asterisk, and conservative and semi-conservative substitutions are 
indicated by a colon and a dot, respectively. 
The present study makes use of a wide range of biophysical techniques, ranging from 
far-UV CD spectroscopy to fluorescence spectrophotometry, to indirectly measure 
the interaction between Nfs1 and Isd11. The most direct means of structurally 
dissecting the Nfs1/Isd11 protein complex would be X-ray crystallography or cryo-
electron microscopy. Small-angle X-ray/neutron scattering could also provide low-
resolution structural information and monitor conformational changes upon complex 
formation. In addition, each of these direct methods would either support or refute 
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the existence of the (Nfs1/Isd11)3 heterohexamer, which is suggested by size-
exclusion chromatography and analytical ultracentrifugation in this study. 
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Appendix 
HyperLadder I (Bioline) 
 
 
SeeBlue Plus2 Pre-Stained Standard (Invitrogen) 
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Cloning/expression region of pET-14b (Novagen) 
 
 
Cloning/expression region of pET-3a (Novagen) 
 
 
Cloning/expression regions of pCDFDuet-1 (Novagen) 
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Genotype of α-Select Competent Cells (Bioline) 
F
-
 deoR endA1 recA1 relA1 gyrA96 hsdR17(rk
-
, mk
+
) supE44 thi-1 phoA 
Δ(lacZYA-argF)U169 Φ80lacZΔM15 λ- 
 
 
Genotype of RosettaBlue(DE3) Competent Cells (Novagen) 
endA1 hsdR17(rK12
-
 mK12
+
) supE44 thi-1 recA1 gyrA96 relA1 lac (DE3)  
[F' proA
+
B
+
 lacI
q
 ZΔM15 ::Tn10] pRARE2 (CamR, TetR) 
 
 
Genotype of RosettaBlue(DE3)pLysS Competent Cells (Novagen) 
endA1 hsdR17(rK12
-
 mK12
+
) supE44 thi-1 recA1 gyrA96 relA1 lac (DE3)  
[F' proA
+
B
+
 lacI
q
 ZΔM15 ::Tn10] pLysSRARE2 (CamR, TetR) 
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Deduced sequence of S. cerevisiae Nfs1 (UniProtKB entry P25374) 
 
 
Deduced sequence of S. cerevisiae Isd11 (UniProtKB entry Q6Q560) 
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Favourite quote 
“Life is nothing but an electron looking for a place to rest.” (Nobel-prize-winning biochemist 
Albert Szent-Györgyi) 
